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CHAPTER 1 
INTRODUCTION 
1.1  Proteases in canceri 
 For years proteases have been implicated as causal in invasive processes 
in cancer (local and during metastatic spread). The complete repertoire of 
proteases known to be associated with cancer, i.e., the cancer degradome, 
includes proteases of five catalytic types: aspartic, cysteine, metallo, serine and 
threonine (Edwards et al., 2008).  Examples of proteases that represent the five 
catalytic types are: cathepsin D (aspartic), caspases and cathepsin B (cysteine), 
MMP-9 and ADAM10 (metallo), plasmin and cathepsin G (serine), and the 
proteasome (threonine) (Rawlings et al., 2010).  Proteases are commonly 
thought to be required only for degradation of extracellular matrices in order for 
the cancer cell to move from its original site.  However, the roles of proteases in 
cancer are much broader, including roles in premalignant lesions, growth, and 
angiogenesis.  Furthermore, the proteases themselves derive not only from 
tumor cells, but also from the multiple cell types present in the tumor stroma, 
e.g., fibroblasts, macrophages, mast cells, leukocytes, and endothelial cells.  
Indeed, there is an extensive body of literature on “proteases in cancer” with over 
7000 reviews found on pubmed.  Despite all that has been found, there is still 
much to unravel.  
 An impediment to determining how proteases function in tumors is that a 
purified protease capable of cleaving a potential extracellular matrix substrate in 
vitro may not be the protease or the single protease responsible for degradation 
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of that substrate in vivo.  Furthermore, any one protease may be targeted to 
different substrates during the early and late stages of tumor progression (for 
recent comprehensive reviews on proteases in cancer, see (Edwards et al., 
2008)).  The in vivo functions of proteases are being studied through the use of 
transgenic mice deficient in specific proteases.  Such studies have been 
informative for pulling out specific functions of a single protease in vivo as 
opposed to inhibitors that may affect other family members.  There are several 
reasons that suggest that this approach is not feasible for all proteases including: 
1) the large number of proteases, 2) the interplay between proteases and their 
endogenous inhibitors and activators, and 3) the redundancy among proteases 
and the observations of compensatory changes in other proteases.  The daunting 
number, ~560, of proteases in the human genome limits studies in both cost and 
time to explore each individually (Cal et al., 2007; Puente et al., 2003; Rawlings 
et al., 2010).  Cathepsin B is an example of a protease that needs to have a 
strong consideration of the interplay with inhibitors/activators as a mechanism of 
its regulation.  Cathepsin B can self activate by cleavage of the pro-peptide or it 
can be cleaved by another protease (e.g., Cathepsin D).  Additionally, outside of 
the lysosome the active enzyme is quickly inhibited by endogenous inhibitors 
either stefins and cystatins depending on the localization intra or extracellularly, 
respectively (Sloane et al., 1990).  An example of the redundancy occurs for 
lysosomal cysteine cathepsins in a transgenic murine model for the development 
of mammary cancer that has established presence of cathepsin B at the surface -
-- in mice deficient in cathepsin B there is altered cell surface expression of 
	  	  
3	  
cathepsin X (Vasiljeva et al., 2006).  However, in addition to compensational 
roles among proteases within the same catalytic-type family members, there are 
additional challenges when considering all the different catalytic-types.  For 
example the deficiency of a serine protease might result in alterations in a matrix 
metalloproteinase (MMP), and these types of changes are harder to predict or 
detect.  Although the complexity of the biological roles of proteases might be 
analyzed more successfully in genetically engineered murine cancer models in 
which the protease gene alleles are latent, conditional or inducible (for review, 
see (Tuveson and Jacks, 2002; Van Dyke and Jacks, 2002)), the use of such 
models will likely be restricted to only a few proteases for the above reasons.       
 Tumor invasion and metastasis are often assumed to be processes that 
involve only extracellular proteases and membrane proteases, e.g., MMPs, 
membrane type-MMPs (MT-MMPs) such as MT1-MMP or MMP-14 and type II 
transmembrane serine proteases (TTSPs) such as matriptase (for reviews (List, 
2009; List et al., 2006; Strongin, 2010)).  In addition to extracellular proteases 
intracellular proteases are also, although less commonly, implicated in tumor 
invasion and metastasis.  Intracellular proteases frequently mediate invasion in 
lower organisms such as parasites.  Invasion of plasmodium and toxoplasma, the 
parasites responsible for malaria and toxoplasmosis, respectively, occurs as a 
result of the secretion of vacuolar cysteine proteases and can be abolished with 
cysteine protease inhibitors (for reviews, see (Binder and Kim, 2004; McKerrow 
et al., 2006; Rosenthal, 2004)).  The working hypothesis in our laboratory has 
been that the mammalian counterparts of these enzymes, i.e., the lysosomal 
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cysteine cathepsins, play comparable roles in the invasive processes associated 
with human cancers (for review, see (Mohamed and Sloane, 2006)).  As 
discussed below, these proteases are secreted from tumor cells and some bind 
to the cell surface.  Whether the primary role of cysteine cathepsins in cancer is 
pericellular, intracellular or both is not yet clear.  We have shown that cysteine 
cathepsins degrade extracellular matrix proteins intracellularly in highly invasive 
BT59 breast carcinoma cells, yet pericellularly in less invasive BT20 breast 
carcinoma cells (Sameni et al., 2000).  Others have confirmed an intracellular 
role of cysteine cathepsins in degradation of collagens, degradation that is 
causally linked to invasive growth of mammary tumors (Curino et al., 2005), 
progression of prostate cancers (Kogianni et al., 2009) and migration and 
invasion of glioma cell lines (Takahashi et al., 2011).  The collagens are taken up 
into the lysosomes via the endocytic collagen receptor uPARAP (urokinase 
plasminogen activator receptor associated protein)/Endo180.  Activity of MT1-
MMP, activation of MMP-2 by MT1-MMP and activity of urokinase (uPA) all have 
been shown to be regulated by uPARAP (Messaritou et al., 2009), indicative of 
functional interactions among pericellular and intracellular proteases that 
contribute to collagen degradation.  
 Sylven and colleagues reported an association of lysosomal proteases 
with cancer in 1957 (Sylven and Malmgren, 1957) and later specifically an 
association of cathepsin B with tumor cell surfaces (Sylven et al., 1974).  
Subsequent studies reported secretion of lysosomal proteases: cathepsin B from 
human breast carcinoma explants (Poole et al., 1978; Recklies et al., 1980); 
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cathepsin L, another cysteine protease, from transformed murine fibroblasts (Gal 
and Gottesman, 1986); and cathepsin D, an aspartic protease, from the human 
MCF7 breast carcinoma cell line (Morisset et al., 1986).  Studies by our 
laboratory established an association between expression of cathepsin B and 
malignancy of murine melanomas (Sloane et al., 1981; Sloane et al., 1982).  We 
identified mechanisms that increase secretion of pro and mature forms of 
cathepsin B and a binding partner that mediates association of pro-cathepsin B 
with caveolar lipid rafts (Figure 1.1A) and invadopodia (Figure 1.1B) on the tumor 
cell surface (for reviews, see (Cavallo-Medved et al., 2011; Mohamed and 
Sloane, 2006; Rothberg et al., 2012; Victor and Sloane, 2007)).  
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Figure 1.1A.  
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Figure 1.1B. 
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Figure 1.1  Caveolae (A) and invadopodia (B) cluster proteases in networks 
at the cell surface.  There are structural similarities between caveolae and 
invadopodia e.g. both require caveolin-1 and lipid rafts for formation. (A) 
Caveolae are a subset of lipid rafts in the plasma membrane, which form flask-
shaped invaginations as a result of the interactions of dimerized caveolin-1. 
Many proteases associated with extracellular matrix degradation are localized to 
caveolae, e.g., plasmin[ogen], MMP-2, -9 and 14 and cathepsin B (CTSB).  For 
some proteases this is the result of binding to receptors, e.g., uPA to uPAR and 
plasmin[ogen] and CTSB to the annexin II heterotetramer. MMP-14 is a 
transmembrane MMP, which is also known as MT1-MMP, whereas uPAR is 
inserted into the membrane by a GPI anchor and is also part of a trimeric 
complex with β1-integrin and uPARAP, an endocytic receptor associated with 
collagen uptake. (B) Invadopodia are membrane protrusions associated with 
filamentous actin and extracellular matrix degradation. MMP-14 and fibroblast 
activation protein (FAP) or seprase accumulate in invadopodia membranes.  In 
the case of other proteases such as, MMP-2 and lysosomal cysteine cathepsins 
(e.g., CTSK, CTSL, CTSX), there is increased secretion from invadopodia. 
Depicted here is a lysosome releasing several cysteine cathepsins following 
trafficking to the membrane on a microtubule (grey). The hexagon shapes 
represent MMPs and pro-MMPs have an additional swoosh representing their 
pro-peptide. 
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1.2  Cathepsin B 
 Cathepsin B is a cysteine protease and a member of the Clan-C1-papain 
family.  The human gene for cathepsin B is located within on chromosome 8 p22 
(Fong et al., 1992).  Cathepsin B is transcribed as a 339 amino acid pre-
proenzyme that cotranslationally loses the 17 amino acid pre-peptide as it enters 
the rough endoplasmic reticulum (reviewed in (Moin et al., 1992; Mort and Buttle, 
1997)).  Pro-cathepsin B has a molecular weight of 43- to 46-kDa depending on 
its glycosylation status.  Normal trafficking of pro-cathepsin B to the lysosome 
follows the classic lysosomal mannose-6-phosphate pathway (Tanaka et al., 
2000).  In this pathway [reviewed in (Coutinho et al., 2012)], lysosomal proteins 
containing the N-linked oligosaccharides tagged with the mannose-6 phosphate 
are recognized and bound by mannose-6-phosphate receptors (MPR) in the 
trans-Golgi.  They remain associated as the budding vesicles are released and 
sorted to deliver the lysosomal hydrolases (e.g., cathepsin B) to the endosomes 
that will ultimately develop into mature lysosomes. Pro-cathepsin B disassociates 
from MPRs in response to a drop in pH characteristic of the late endosomes at 
~pH 6 and then the empty receptors are recycled back to Golgi.  In the 
lysosomes cathepsin B undergoes maturation to its active form as either the 31-
kDa single or 25/26-kDa plus 5-kDa double chain form linked by a disulfide 
bridge (Kawabata et al., 1993; Ritonja et al., 1985).  In the lysosomes cathepsin 
B has a broad substrate specificity to help in degradation and protein turnover 
(Rawlings et al., 2010).  
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 Cathepsin B is a bi-lobal protein with the active site interface between two 
globular domains.  Uniquely among other C1-papain family members cathepsin B 
is a dual functional protease because in addition to catalyzing peptide cleavages 
as an endopeptidase it can also cleave substrates as an exopeptidase (peptidyl-
dipeptidase) (Barrett and Kirschke, 1981) (Figure 1.2).  The evolutionary origin of 
cathepsin B suggests that it may have originated as endopeptidase similar to 
other C1-papain family members, but the 21 amino acid insertional group termed 
“occluding loop” gives cathepsin B an additional and presumably dominant 
function as a carboxypeptidase.  Only three other family members have a 
catalytic function other than endopeptidase activity: cathepsins H and X and 
dipeptidyl-peptidase-1 are both exclusively exopeptidases (Rawlings et al., 
2010). Mouse models have supported that the dual activity of cathepsin B is 
functional in vivo because cathepsin L (endopeptidase) and cathepsin X 
(exopeptidase) have been shown in different experimental models to 
compensate for the absence of cathepsin B (Sevenich et al., 2006; Sevenich et 
al., 2010; Vasiljeva et al., 2006).   
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Figure 1.2.  Active cathepsin B is a protease with dual functions as a result of an 
occluding loop (arrow). At an acidic pH (pink- left), cathepsin B acts as an 
exopeptidase that cleaves the substrate by removing two amino acids at the 
carboxy terminus. At a neutral pH (blue - left), cathepsin B acts as an 
endopeptidase that cleaves the substrate (green) in the middle. The occluding 
loop modulates the two activities. At an acidic pH, the loop blocks the active site 
cleft, whereas at a neutral pH the loop is lifted allowing the substrate entry to the 
active site cleft. 
Figure 1.2.  Active cathepsin B is a protease with dual functions as a result of an occluding 
loop (arrow).   At an acidi  pH (pink- left), cath psin B acts as an exopeptid se th t cleaves 
the substrate by emoving two amino cids at the carboxy terminus.  At a neutral pH (blue - 
left), cathe sin B acts as an endopeptidase that cleav s the substrate (green) in the 
middle. The cc uding loop modula es the two tivities. At an acidic pH, the loop blocks the 
active site cleft, where s at a neutral pH the loop is lifted allowing the ubstrate entry to the 
active site cleft.
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 Mature cathepsin B is active at both slightly acidic and neutral pH with the dual-
pH-optimum being regulated by an occluding loop (Illy et al., 1997; Nagler et al., 
1997).   This flexible occluding loop has pH-sensitive histidine residues (His110 
and His111) that stabilize the occluding loop within the prime region of the active-
site cleft (Musil et al., 1991; Nagler et al., 1997).  In an acidic environment the 
occluding loop partly blocks one side of the active site interface and provides an 
anchor for C-terminal substrates allowing successful proteolytic cleavage of 
dipeptides at the carboxy terminus of proteins (Figure 1.2).  In a neutral 
environment the deprotonation of histidines provides more flexibility in the 
occluding loop and further exposes the active site allowing substrates to more 
readily displace the occluding loop, leading to cleavage of internal peptide bonds 
within protein substrates (Khouri et al., 1991; Nagler et al., 1997). The 
endopeptidase catalytic activity has a more neutral pH optima, around pH 7.4 
(Khouri et al., 1991; Nagler et al., 1997); others have suggested that cathepsin B 
has endopeptidase activity at low pH in studies using synthetic fluorescent 
peptide substrates (Ruzza et al., 2006).  
 This dual function protease has been implicated for many years as a 
mediator of invasion and metastasis and is of interest to this study because of its 
ability to function within the pH range found in the interstitial fluids around human 
breast tumors. In breast and other types of cancers cathepsin B has been shown 
to have an altered intracellular trafficking pattern (Campo et al., 1994), an 
association with the plasma membrane, and to be secreted in both active and 
inactive forms (Poole et al., 1978; Rozhin et al., 1994). Aberrant cathepsin B 
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activity and localization have been attributed in part to alterations in the 
expression of cathepsin B as mediated by gene amplification, increased 
transcription, increase in mRNA stability, use of alternative promoters, and 
alternative splicing (Yan and Sloane, 2003).  Other cells besides transformed 
epithelial cells have elevated levels of cathepsin B in the tumor 
microenvironment, such as cancer-associated macrophages (Campo et al., 
1994; McKerrow et al., 2000). The Sloane laboratory has found that growth of 
human breast fibroblasts on collagen I alters cell morphology and results in 
increased expression of cathepsin B and secretion of pro-cathepsin B (Koblinski 
et al., 2002). Furthermore, an acidic extracellular pH (pHe) has been shown to 
induce redistribution of cathepsin B from perinuclear lysosomes towards the cell 
periphery and/or secretion in melanoma and breast cancer cells (Rozhin et al., 
1994); for review see (Rothberg et al., 2012) and Figure 1.3.  
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Figure 1.3.  An acidic microenvironment is generated by tumors and 
enhances invasion and degradation of the extracellular matrix.  The scissors 
indicate cleavage of the basement membrane protein collagen IV. In response to 
acidic pH pericellularly, vesicles redistribute to the cell periphery via a 
microtubule-dependent process, possibly leading to the observed secretion of 
active CTSB from lysosomes and proCTSB from secretory vesicles from breast 
cancer cells.  This also includes secretion of lysosomal glycosidases such as 
hyaluronase-2 (Hyal-2), which cleaves hyaluronan and releases bioactive 
molecules that had bound to this matrix component (stars). 
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1.3    Importance of cellular context:  In vitro study of cancer in 3D 
 Historically, in vitro tissue culture conditions have not taken into account 
the non-cellular tumor microenvironment (Maltman and Przyborski, 2010).  One 
of the key components of a cell’s environment is the matrix that surrounds it (Lu 
et al., 2012). There are many changes that occur in cells that are cultured with or 
without extracellular matrix (Howlett and Bissell, 1993).   Limitations of traditional 
tissue culture methods include, but are not limited to: loss of tissue-specific 
architecture, mechanical and biochemical signaling, and types of cell-cell 
communication.  These changes lead to altered downstream gene expression 
and changes in metabolism. The lost signaling and attachment cues can be 
restored along with proper polarization in 3D culture systems (Petersen et al., 
1992); further reviewed in (Bissell and Radisky, 2001).   
 There are many matrices to choose from for a 3D scaffold for solid tumor 
growth.  What makes a good matrix for 3D growth and study of proteases (with a 
focus on imaging)?  It should have biological context with components of the 
natural environment, e.g., recognizable matrix for proper integrin signaling for 
proper polarization.  One should be able to easily separate the matrix from the 
cells to assess changes in select proteins, DNA and RNA. To observe proteolytic 
activity the matrices should be degradable.  However, others contend that 
matrices don't need to be degraded to allow movement of tumor cells through 
stromal tissues (Friedl and Wolf, 2003; Wolf et al., 2003a; Wolf et al., 2003b; 
Wyckoff et al., 2006).   The matrix should be translucent for imaging by confocal 
microscopy and detection of fluorescent markers in real-time (Smith et al., 2010).  
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Matrix degradation should be quantifiable after protease cleavage such as 
through use of fluorescence, biotin, and/or antibodies (Jedeszko et al., 2008; 
Moin et al., 2012).  Several matrices can meet these requirements such as those 
derived by electrospinning or hydrogels, e.g., reconstituted basement 
membranes (rBM).  Additionally there are many other matrix systems that 
support 3D tissue growth albeit in non-degradable matrices (i.e, electrospun 
synthetic fibers).  There are benefits and caveats to each, but all try to address 
the limitations associated with 2D cultures.   
 Our laboratory conducts studies in 3D using a rBM overlay model 
optimized by Brugge and colleagues (Debnath et al., 2002; Debnath et al., 2003).  
Natural components of basement membranes are isolated and purified from 
Engelbreth-Holm-Swarm (EHS) sarcoma tumor extracts grown in vivo, marketed 
as MatrigelTM or CultrexTM.  The history and uses of the rBM are reviewed in 
Kleinman and Martin (Kleinman and Martin, 2005).  This commercially available, 
easy to store and manipulate basement membrane extract provides physiological 
context.  Indeed, elegant studies by Bissell and colleagues using rBM and diploid 
breast cells established integrin dependent polarity and functional morphology 
characteristic of the site of origin, i.e., breast acinar ductal cells differentiating into 
milk- or casein-producing epithelium (Bissell et al., 2002; Petersen et al., 1992).  
The main caveat of the rBM 3D models is the unpredictability of these naturally 
derived extracellular matrixes which are undefined and could lead to altered 
behaviors or signaling mechanisms due to batch-to-batch variability. To over 
come this limitation our laboratory and others, are using the same lot as much as 
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possible throughout a study to reduce the variability.  In addition to considering 
an appropriate matrix for the studies, other non-cellular microenvironmental 
aspects should be considered, such as the pH. 
1.4   Acid-Mediated Invasion Hypothesis 
 A majority of solid tumors have an acidic microenvironment (Wike-Hooley 
et al., 1984) with the extracellular pH (pHe) in tumors ranging from 5.3-7.2 
(Gillies et al., 2002; van Sluis et al., 1999). Acidification has been attributed to a 
combination of factors including chaotic tumor vasculature, increased glycolysis 
and diminished buffering capacity of tumor interstitial fluids (Stubbs et al., 1994).  
These factors lead to high concentrations of extracellular lactic acid surrounding 
the tumors.  The key mediator --- increased glycolysis --- is a component of 
reprogramming of energy metabolism, one of the emerging hallmarks of cancer 
(Hanahan and Weinberg, 2011); also see (Figure 1.4).  The concept that 
metabolism is altered in cancer dates back to the observation made by Otto 
Warburg that tumor cells exhibit increased glucose breakdown via glycolysis 
despite the presence of oxygen (Warburg et al., 1927).  Byproducts of elevated 
glycolytic activity result in an acidic pHe that varies among different types of solid 
tumors and is heterogeneous within a single tumor (Gillies et al., 2002; van Sluis 
et al., 1999; Wike-Hooley et al., 1984). 
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Figure 1.4. Selection barriers impede the progression of cancer and give 
rise to the hallmarks of cancer. The fundamental idea driving our study is that 
adaptation of cancer cells overcomes selection barriers and result in the 
hallmarks of cancer.  Cancers must overcome all of the barriers, but this can be 
accomplished in various ways.  For example, alterations in a single 
multifunctional protein such as Ras or hypoxia-inducible factor 1α may initially 
serve to overcome one barrier, but then accelerate the subsequent pace of 
somatic evolution by lowering other barriers. The barriers are used as “crucial 
mathematical parameters” to model of the acid-mediated invasion hypothesis 
(Gatenby and Gillies, 2008).  Our study looks at the pre-malignant to invasive 
stages of breast cancer where intermittent hypoxia selects for cancer cells that 
have an altered metabolic phenotype of anaerobic glycolysis and that consume 
large amounts of glucose.  This metabolic shift can remain even in the presence 
of adequate vasculature and oxidation.  Glycolysis produces large quantities of 
lactic acid, which is secreted and, when coupled with other factors, results in an 
acidic tumor microenvironment.  This acidosis creates a supportive environment 
for basement membrane degradation and invasion through increased activity of 
proteases.   
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Acidification of the tumor microenvironment has been shown to cause acid-
mediated toxicity in the surrounding normal cells and providing empty space for 
tumor cell proliferation and invasion through proteolytic remodeling of 
extracellular matrix (Figure 1.4). The cancer hallmark of resistance to apoptosis 
can be subcategorized to resistance to apoptosis mediated by acid-mediated 
toxicities (Gatenby and Gillies, 2008).  Normal cells begin undergoing cell death 
at pH < 7.3 with an apoptotic threshold at pH 7.1 (Casciari et al., 1992). 
Acidifying the microenvironment adversely affects surrounding normal cells 
pushing them towards death either by necrosis, apoptosis, or other means, 
whereas the cancer cells largely resist acid-mediated death (Martin et al., 2010).  
During the premalignant stages of tumorigenesis, cancer cells develop a 
resistance to the toxicity of an acidic microenvironment (Gatenby et al., 2007).  
Acid-resistant cells survive and proliferate in low pH environments.  One recently 
suggested mechanism by which cancer cells adapt and survive in an acidic 
microenvironment is the up-regulation of chronic macroautophagy (Wojtkowiak et 
al., 2012).  Autophagy as a survival mechanism in cancer is controversial. 
Mashima et al. (2009) alternatively offered acytl-CoA synthetase 5 activities as a 
probable mediator for the acidosis survival mechanism in glioma cells.  The 
acidic tumor microenvironment effectively eliminates normal cells that compete 
for the same nutrients and space as the cancer cells, giving the cancer a survival 
advantage over the normal cells.  
  Acidosis assessed via elevated glycolysis has been shown to persist in 
areas of adequate oxygen (Cherk et al., 2006; Fukumura et al., 2001; Hjelmeland 
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et al., 2011).  The acid-mediated invasion hypothesis is supported by a large 
quantity of correlative data, including: 1) reaction diffusion modeling (Gatenby 
and Gawlinski, 1996); 2) increased metastasis formation following acid-pre-
treatment (Moellering et al., 2008; Rofstad et al., 2006; Schlappack et al., 1991); 
3) peritumoral acidosis measured by intravital microscopy (Gatenby et al., 2006) 
and 4) inhibition of spontaneous and experimental metastasis following acid-
neutralization with buffers (Ibrahim-Hashim et al., 2012; Ibrahim-Hashim et al., 
2011a; Ibrahim-Hashim et al., 2011b; Robey et al., 2009).   
 Prior experiments have shown that low pH is associated with increased 
protease activity (Martinez-Zaguilan et al., 1996) and increased release of active 
cysteine cathepsins in 2D culture models (Robey et al., 2009; Rozhin et al., 
1994).  This increase in active proteases may enhance invasion since in tumor 
xenografts invasion has been shown to occur more often in regions where the 
pHe is acidic (Estrella et al., 2013).  Previous studies from our laboratory and 
others suggest that an acidic peritumoral microenvironment provides a 
supportive environment for proteases that have an acidic pH optimum, such as 
cathepsin B or other lysosomal proteases.   Indeed, of the 11 cysteine 
cathepsins, more than half have been linked to breast cancer progression: 
cathepsins B, L, H, K, S, V and X (Watson and Kreuzaler, 2009).  An acidic pHe 
induces redistribution of endosomes and lysosomes to the cell surface and 
increases release of cysteine cathepsins (Glunde et al., 2003; Rozhin et al., 
1994; Steffan et al., 2009).   My study builds off these prior studies as I examine 
the effects of an acidic pHe in the breast tumor microenvironment. 
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CHAPTER 2 
MATERIALS AND METHODS 
2.1  Materials  
 Dimethyl sulfoxide (DMSO), Dulbecco’s Modified Eagles Medium 
(DMEM), Dulbecco's Modified Eagle's Medium/Nutrient F-12 Ham (DMEM/F12), 
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), hydrocortisone, 
insulin from bovine pancreas, NaHCO3, piperazine-N,N′-bis(2-ethanesulfonic 
acid) (PIPES), thiazolyl blue formazan (1-(4,5-dimethylthiazol-2-yl)-3,5-
diphenylformazan, and all other chemicals not otherwise noted were obtained 
from Sigma (St. Louis, MO).  Fetal bovine serum (FBS) was purchased from 
Hyclone (Logan, Utah); Epithelial Growth Factor (EGF) from R&D Systems 
(Minneapolis, MN); Mammary Epithelial Media 171 (M171) and Mammary 
Epidermal Growth Factor Supplement (MEGS) from Cascade Biologics 
(Portland, OR); Z-Arg-Arg-NHMec (Bachem, Torrence, CA); CA074, E64, from 
Peptides International (Louisville, KY); pimonidazole HCl from Hypoxyprobe, 
(Burlington, MA); and Ventana OmniMap anti-Rabbit HRP from Roche 
(Indianapolis, IN). Reconstituted basement membrane (rBM): in vitro studies 
used reduced growth factor CultrexTM from Trevigen (Gaithersburg, MD); in vivo 
studies used MatrigelTM (BD Biosciences, San Jose, CA). CellTrackerTM orange, 
Click-IT EDU (5-­‐ethynyl-­‐2´-­‐deoxyuridine) microplate assays, DQ-collagen IV, 
Hoechst 33342, horse and goat serum, live/dead kit, 3-(4,5-Dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) and trypsin-EDTA were purchased from 
Life Technologies (Grand Island, NY). Pierce Protein A/G Plus Agarose beads 
	  	  
23	  
(Thermo Scientific, Rockford, IL) and anti-rabbit cathepsin B, anti-rabbit pre-
immune IgG (Moin et al., 1992), anti-rabbit cathepsin S (a kind gift of Dr. Boris 
Turk, Jozef Stefan Institute, Ljubljana, Slovenia), anti-goat cathepsin S (R&D 
Systems) and anti-rabbit cathepsin L (Dr. Ekkehard Weber, Martin Luther 
University, Halle, Germany) antibodies were used for immunoprecipitations.  
GB123, an activity based probe (ABP) for cysteine cathepsins (Blum et al., 
2005), was provided by Dr. Matthew S. Boygo (Stanford University, Palo Alto, 
CA). 
2.2  Tissue Culture  
 We utilize the MCF10A progression series to model breast cancer 
progression the as well as other human derived cell lines to complement this 
system.  Figure 2.1 demonstrates the MCF10A progression series related to the 
progression of ductal breast carcinoma as well as indicating the other cell lines 
used in this study.  In addition to the MCF-10A breast cancer progression series 
(MCF10A, MCF10-AT1, MCF10-AT3B, MCF10.DCIS, and MCF10-CA1D) 
obtained from the Cell Lines Resource (Karmanos Cancer Institute, Detroit, MI) 
other human cell lines used and where they are from include: normal mammary 
myoepithelial cells (N1ME) were a kind gift from Dr. Kornelia Polyak (Dana-
Farber Cancer Institute, Boston, MA); tumor-associated human mammary 
fibroblasts (WS-12Ti) were a kind gift from Steve Santner (KCI, Detroit, MI).  
Invasive triple negative breast cancer (TNBC) MDA-MB-231 [American Type 
Culture Collection (ATCC)] and MDA-MB-231 stably transfected with red 
fluorescent protein (RFP) and luciferase (Luc) (Robey et al., 2009), and Hs578T 
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from Dr. Raymond Mattingly were used along with colon carcinoma HCT116 from 
ATCC, and patient-derived DCIS breast cells SUM 102 and SUM 225 as a kind 
gift from Dr. Stephen P. Ethier (KCI / MUSC).  Low passages of all cells were 
maintained at pH 7.4 with antibiotics (penicillin/streptomycin) in the absence of 
phenol red due to its estrogenic properties under humidified conditions under 
atmospheric oxygen levels and 5% CO2.  Cells were monitored by microscopy to 
confirm that they maintained their original morphology and were regularly 
screened for mycoplasma by microscopy (MycoFluor, Invitrogen) and RT-PCR 
(LookOut, Sigma).   For subculturing, cells were detached from tissue culture 
treated flasks with 0.05% trypsin-EDTA (except MCF10.DCIS cells which were 
detached using 0.25% Trypsin-EDTA).   MCF10-A, -AT1, and -AT3B were 
maintained in DMEM/F12 supplemented with 5% horse serum, 5 ng/ml EGF, 100 
µg/ml insulin, and 1 µg/ml hydrocortisone.  MCF10-DCIS and –Ca1D were 
maintained in DMEM/F12 supplemented with 5% horse serum. WS-12Ti were 
maintained in DMEM/F12 medium supplemented with 10% FBS.  The MDA-MB-
231-RFP/LUC, Hs578T, and HCT116 cells were maintained in DMEM 
supplemented with 10% FBS. SUM102 and SUM225 were maintained in Ham's 
F-12 medium supplemented with 10% fetal bovine serum and N1ME cells were 
maintained in M171 media supplemented with MEGS. 
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Figure 2.1. 
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Figure 2.1.  MCF10 progression series and other cellular models used.  The 
MCF10 progression series consists of several isogenic cell lines that model 
breast cancer progression from a non-transformed, spontaneously immortalized 
diploid cell line to invasive ductal carcinoma of the triple negative breast cancer 
(TNBC) subtype.  Shown in this image from the breastcancer.com website is a 
cartoon of the stages of breast cancer progression as visualized through a cross 
section of a duct.  In the normal duct, there is a single layer of ductal epithelial 
cells, a phenotype corresponding to structures formed in vitro in 3D cultures by 
MCF-10A cells.  The subsequent derivatives of the 10A cell line are shown in 
pink boxes alongside corresponding to stages of malignant progression.  In 
addition to the MCF10.DCIS and CA1D cells, we analyzed patient-derived cell 
lines that represent DCIS (SUM 102 and SUM 225) and highly malignant 
carcinomas (MDA-MB-231 and Hs578T), depicted here in blue boxes.  We also 
used human breast tumor-associated fibroblasts (WS-12Ti) and human normal 
breast myoepithelial cells (N1ME) and one non-breast cancer cell line, i.e., 
HCT116 colon carcinoma cells, as depicted in the white boxes.   
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2.3 3D culturing 
 We use an overlay method for growing 3D structures of cells designed by 
Bissell and colleagues (Bissell et al., 1999; Howlett and Bissell, 1993; Weaver 
and Bissell, 1999) and further optimized by Joan Brugge and colleagues 
(Debnath and Brugge, 2005; Debnath et al., 2002).  Single cell suspensions of an 
appropriate number of cells per desired volume are placed on solidified reduced 
growth factor Cultrex.  When the cells are adherent the medium containing 2% 
reduced growth factor Cultrex is placed over the cells.  For detailed methods see 
(Sameni et al., 2012).  For experiments testing the effects of pH, the medium 
were additionally buffered to maintain pH 7.4 or 6.8 with 2 g/L sodium 
bicarbonate, 25 mM of PIPES, and HEPES and then incubated overnight at 37 
°C in 5% CO2 (Robey et al., 2009). 
2.4  Live Cell Assays for Proteolysis and Active Cysteine Cathepsins 
 A detailed protocol for the live cell proteolysis assay has been published 
(Jedeszko et al., 2008).  Briefly, glass coverslips in 35-mm dishes were coated 
with 45 µl of Cultrex rBM containing 25 mg/ml of DQ-collagen IV (Figure 2.2) and 
placed in a 37 °C incubator for 10 min to allow solidification.  Approximately 
50,000 cells were seeded on top of the Cultrex and incubated at 37 °C for 30-60 
min until adherent, at which point either pH 7.4 or 6.8 culture media containing 
2% rBM were applied (Figure 2.2). Media were changed the following day.  For 
inhibitor studies, 20 µM CA074/E64 or an equal volume of DMSO was added to 
the Cultrex before solidification as well as to the media overlay.  To visualize 
active cysteine cathepsins the same setup applies with the addition of 1 mM of 
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GB123, an ABP (Blum et al., 2005; Blum et al., 2007), to media for 16-18 hours 
prior to imaging (Figure 2.2).  Cells were washed thoroughly in phosphate 
buffered saline (PBS) to remove any unbound probe and returned to probe-free 
complete growth medium at either pH 7.4 or 6.8 for at least one hour prior to 
imaging. The nuclei were labeled with Hoechst 33342 just before imaging.  All 
experiments were imaged with a Zeiss LSM 510 META NLO confocal 
microscope using a 40X water-dipping objective to capture the 3D structures 
(Figure 2.3A).  Cell number was determined with Volocity™ software (Figure 
2.3B). The intensity of the fluorescent signal per cell was measured using 
MetaMorph™ and Volocity™ software.  Localization of active cysteine cathepsins 
was determined using MetaMorph™ software.  RFP expression or CellTrackerTM 
orange staining were utilized to determine cell boundaries, as described 
previously (Jedeszko et al., 2008) (Figure 2.3). 
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Figure 2.2.  Live cell imaging of proteolytic activity.  A) Cartoon of the 
confocal imaging setup, showing the dipping lens submerged in buffered culture 
medium (DMEM) maintained at either neutral (7.4) or slightly acidic (6.8) pH and 
containing 2% rBM. Fluorescent cells either expressing RFP or pre-labeled with 
CellTracker Orange are grown in 3D rBM overlay cultures.  B) DQ-collagen IV is 
mixed with Cultrex prior to solidification and upon proteolytic cleavage emits 
green fluorescence.  C) Chemical structure of GB123, an activity-based probe 
(ABP) for cysteine cathepsins, is shown.  The ABP is added to the media the day 
before imaging and washed to remove unbound probe prior to imaging. GB123 
covalently binds to its target proteases, e.g., cathepsin B, allowing for Cy5 
detection of the protease.   
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Figure 2.3.  Active cysteine cathepsins and degradation fragments of DQ-
collagen IV could be detected in breast carcinoma cells grown in 3D rBM 
overlay cultures.  A) 3D reconstruction of optical sections taken through the 
entire volume of an MDA-MB-231 3D culture: with red representing RFP in the 
cytoplasm; blue representing Hoechst 33342 stained nuclei; green representing 
degradation products of DQ-collagen-IV; and cyan representing GB123 bound to 
active cysteine cathepsins.  B) Illustration of spatial separation in 3D of nuclei for 
enumeration.  C and D) Single optical sections through the equatorial plane, 
fluorescence was evenly increased to visually differentiate with mask (white) 
illustrating measured DQ-collagen IV degradation fragments and ABPs bound to 
cysteine cathepsins, respectively. Bar, 22.6 µm. 
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2.5 MTT Assay  
 Literature searches suggested disagreement as to the best wavelength to 
measure the formazan absorbance peaks. To determine optimal wavelengths for 
our assay, an absorbance profile from 200-700 nm was recorded for purified 
thiazolyl blue formazan at a 1:5 dilution of 1 mg/ml in DMSO using a BioSpec-
1601, Shimadzu Corporation (Kyoto, Japan) (Figure 2.4).  The multiple 
wavelengths published might suggest lack of available filters in the plate readers 
used.  Plumb et al. (1989) demonstrated that pH of the dilutants can causes 
shifts in the absorbance spectrums.  Here only DMSO was used to lyse cells and 
dissolve the formazan precipitates; nonetheless, absorbance profiles were 
recorded for pooled formazan products from live cells after 3 days of growth in 
3D rBM overlay cultures at either 7.4 or 6.8 to eliminate the possibility of 
absorbance profile shifts under the conditions used for our studies (Figure 2.5).  
A large volume of product solution was required to obtain an absorbance 
spectrum. Therefore, cellular metabolized MTT-products (i.e., formazan) were 
pooled from multiple cell lines, including ones that were not acid-resistant.  This 
attributed to the lower absorbance readings at pHe 6.8.   
 For this assay, each well of a 96-well plate was coated with 15 µl Cultrex 
before adding ~1500 cells/well, followed by 200 µl of either pH 7.4 or 6.8 DMEM 
media containing 2% Cultrex.  On the day of the assay 50 µl of MTT (5 mg/ml) 
stock solution was added to each well to a final concentration of 1 mg/ml MTT.  
The plate was incubated at 37 ˚C for 3 hours to allow formation of the formazan 
crystal product.  Media were removed and replaced with 150 µl DMSO while 
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shaking at room temperature.  Absorbance values were read at 485 nm on a 
Tecan Spectrafluor Plus (Salzburg, Austria). 
 
 
 
 
 
  
Figure 2.4.  Absorbance spectrum of commercially purified formazan, the 
MTT reaction product, dissolved in DMSO.  Lines at 488 and 590 indicate 
available filter settings for the 96-well Tecan Spectrafluor Plus plate reader.   
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Figure 2.5. Absorbance spectrum for formazan is the same for cells 
cultured at pHe 7.4 and 6.8.  Absorbance spectra of dissolved formazan 
products from cells cultured at either pH 7.4 (A) or pH 6.8 (B) are shown.  Lines 
at 488 and 590 indicate available filter settings for the 96-well Tecan Spectrafluor 
Plus plate reader.  
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2.6  Proliferation Assay 
 Cell proliferation was measured via a Click-iT EdU (5-ethynyl-2’-
deoxyuridine) microplate assay in which incorporation of the nucleoside analog, 
EdU, into DNA during active DNA synthesis is assessed.  For this assay, each 
well of a 96-well plate was coated with 15 µl Cultrex before adding ~1500 
cells/well.  To each well, 200 µl of either pH 7.4 or 6.8 DMEM media containing 
2% Cultrex was added.  On day two, EdU was added and the next day the assay 
was performed according to the manufacturer’s protocols.  Fluorescence values 
were read at 568/585 nm on a Gemini SpectraMax (Molecular Devices, 
Sunnyvale, CA). 
2.7 Cell Viability Assay 
 To distinguish living from dead or dying cells under our assay conditions, a 
Live/Dead kit was used.  This assay utilizes differential properties of live and 
dead cells to fluorescently distinguish them.  Live cells have ubiquitous 
intracellular esterase activity, which converts a nonfluorescent cell-permeable 
calcein AM to fluorescent calcein (ex/em ~494 / ~517 nm).  Dead cells, with 
damaged membranes, allow ethidium homodimer-1 (EthD-1) to enter and bind 
nucleic acids thus emitting fluorescence (ex/em ~528/~617 nm).  For this assay 
glass coverslips were coated with 45 µl of Cultrex and placed in a 35-mm dish.  
Cells (~5,000) were seeded on the Cultrex until adherent then covered with either 
pH 7.4 or 6.8 media containing 2% rBM.  Media were changed every three days.  
At the selected endpoints cultures were incubated with assay reagents (PBS 
containing both four µM EthD-1 and two µM calcein AM) for 30 minutes before 
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imaging six to eight fields of view per coverslip at both 485 and 530 nm. For this 
assay calcein positive cells (green) were considered alive, while EthD-1 positive 
cells (red) were considered dead.  However, for cells expressing RFP (MDA-MB-
231-RFP/Luc cells) the RFP and EthD-1 signal overlap making all the cells “red”, 
so calcein negative cells were considered dead (absence of green).  
2.8 Fluorometric Activity Assay for Cathepsin B 
 After growing the cultures at pH 7.4 or 6.8, cathepsin B activity (active and 
latent) in MDA-MB-231 cell lysates and conditioned media was assessed using 
Z-Arg-Arg-NHMec, a selective cathepsin B substrate, as previously described 
(Cavallo-Medved et al., 2009).  To measure intracellular and membrane bound 
cathepsin B activity, 50 µl of sample was treated with 300 µl of activator buffer (5 
mM EDTA, 10 mM DTT, pH 5.2) for 15 min at 37 °C. Endogenous inhibitors 
secreted by the cell inhibit active cathepsin B in the media, but latent or 
procathepsin B activity can be measured by exposing the active site of 
procathepsin B in the presence of negatively charged dextran sulfate (Caglic et 
al., 2007).  Briefly, 50 µl of conditioned media was mixed with 300 µl of citrate 
buffer (20 mM citrate buffer, pH 4.6, 10 mM DTT and 25 µg/ml dextran sulfate) 
and incubated for 45 min at 37 °C, then added in triplicate to a 96-well flat-bottom 
black microtiter plate.  For cell lysates 100 µl of cell lysate/activator buffer mixture 
were added to 200 µl of appropriate assay buffer containing 50 µM Z-Arg-Arg-
NHMec and fluorescence was measured at one-minute intervals for 30 minutes 
using a Tecan SpectraFluor Plus plate-reader at an excitation of 360 nm and an 
emission of 465 nm and activity was reported as picomoles of NHMec formed per 
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min per µg DNA. The highly selective cathepsin B inhibitor CA074 (10 µM) was 
used to confirm the specificity of the assay (Murata et al., 1991).  
2.9  Immunoprecipitation of ABP-bound cysteine cathepsins 
 MDA-MB-231 cells were grown in 3D rBM overlay cultures and the day 
before collection media were changed to serum-free with the addition of 1 µmol/L 
GB123.  On the next day, after washing with PBS and sitting in complete media 
for an hour, cell lysates were collected in ice-cold RIPA buffer (50 mM Tris HCl, 
pH 7.4, 150 mM NaCl, 5 mM EDTA, 0.5% deoxycholate, and 0.1% SDS).  Anti-
rabbit cathepsin B (1:500), anti-rabbit pre-immune IgG (1:500), normal goat 
serum (NGS) (1:250), anti-rabbit cathepsin S (1:250), and anti-rabbit cathepsin L 
(1:250) were individually added and mixed at 4 ˚C overnight.  Alternatively, serial 
immunopreciptaitons were performed using anti-rabbit cathepsin B (1:500), anti-
rabbit cathepsin L (1:250), and anti-goat cathepsin S (1:40).  Pierce Protein A/G 
Plus Agarose beads (30 µl) were then added and mixed overnight at 4 ˚C and an 
additional 30 min at room temperature. Supernatants and beads collected; the 
beads were washed with RIPA buffer and boiled after addition of 2X sample 
buffer (20% glycerol, 100 mM Tris HCl, pH 6.8, 6% SDS, and 10% beta-
mercaptoethanol). Acetone at 0 ˚C was added to the supernatant, and the 
mixture kept at –80 ˚C for 2 h, centrifuged at 14,000 × g at 4˚C for 30 min, and 
the pellet air dried at room temperature and dissolved by boiling in sample buffer. 
Immunoprecipitated proteins were collected by centrifugation at 14,000 × g at 
4˚C for 30 min, air dried at room temperature and dissolved by boiling in sample 
buffer.  Immunoprecipitated proteins and supernatants were separated on 12% 
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SDS-PAGE and the gels visualized using a CCD camera-equipped Bio-Rad 
Versadoc 5000MP imager (excitation/emission 633/680 nm). 
2.10 Animals                      
 Mice were housed according to IACUC protocol at the University of South 
Florida vivarium located within the H. Lee Moffitt Cancer Center (Tampa, FL).  4-
6 week old female SCID-beige mice (Charles River) were used for fluorescent 
imaging of orthotopic tumors. 
2.11   In vivo imaging of active cysteine cathepsins 
SCID mice (n=7) were separated into two cohorts prior to cell injection and 
were provided either tap (n=3) or 400 mM sodium bicarbonate (n=4) drinking 
water.  In preparation for injection, the MDA-MB-231 cells were trypsinized and 
washed once with PBS.  Cells were resuspended at a concentration of 1 x 107 
cells/ 100 µL in a 1:1 mixture of PBS and Matrigel and injected into the right, 
number four mammary fat pad of each mouse.  Tumors were monitored by 
caliper measurements, and when tumors reached ~400 mm3, animals were 
imaged.  18 hours prior to imaging, 25 nmols of GB123 was injected 
intravenously into mice (Blum et al., 2005).  In vivo measurements were obtained 
using an Optix-MX3 (Advance Research Technologies, a subsidiary of SoftScan 
Healthcare Group, Montreal, Canada).  Fluorescent images were acquired using 
a 670-nm pulsed laser diode and a scan resolution of 1.5 mm.  Images were 
analyzed using Optix-MX3 Optiview Software. 
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2.12   Immunohistochemistry of orthotopic tumors 
 Pimonidazole HCl (60 mg/kg; Hypoxyprobe) was injected into the 
peritoneal cavity one hour prior to tumor removal.  MDA-MB-231-RFP tumors 
were formalin fixed and paraffin embedded (FFPE) for immunohistochemcal 
analysis.  FFPE cross-sections were stained with rabbit anti-sera against 
pimonidazole HCl followed by Ventana OmniMap anti-rabbit HRP secondary.   
The detection system used was the Ventana ChromoMap Kit and slides were 
then counterstained with hematoxylin.  Processed slides were scanned using the 
Aperio™ (Vista, CA) ScanScope XT with a 200x/0.8NA objective lens at a rate of 
5 minutes per slide via Basler tri-linear-array. 
Pimonidazole HCl was used to identify hypoxic areas.  However, it does 
not stain necrotic tissue due to the lack of viable cells, although likely hypoxic.  
To segment viable and non-viable tissue, an optimized Aperio Genie® v1 
customized histology pattern recognition algorithm was developed to distinguish 
between tissue types based on various morphologies.  The algorithm was 
applied to the entire slide’s digital image to determine the percentage of each 
tissue type (viable or non-viable) by area (µm2).  Intensity analysis of 
pimonidazole HCl in viable tissue was performed using an Aperio 
PositivePixelCount® v9.0 algorithm with the following optimized thresholds 
[HueValue=0.1; HueWidth=0.5; Iwp(High)=220; Iwp(Low)/Ip (High)=175; 
Ip(Low)/Isp (High)=100; Isp(Low)=0; Inp(High)=-1] to segment positive pixels of 
various intensities.  The percentage of positivity was quantified by the number of 
cells exhibiting positive stain as a percentage of total viable tumor cell count. The 
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staining intensity can be thresholded into negative (0), low (1+), moderate (2+) 
and strong positive (3+) by mean stain density (0-255 dynamic range) for each 
tumor cross section.  Positive pixel analysis was completed using Spectrum 
(Aperio Technologies).     
2.13 RNA isolation for microarray [adapted from (Wojtkowiak et al., 2012)]  
 Three-dimensional cultures were established of ~4.5 x 105 cells each for 
MCF10A, MCF10.DCIS, SUM102, SUM225 and N1ME cell lines.  Cells were 
seeded on 100-mm plates coated with solidified Cultrex.  WS-12Ti fibroblasts 
(~4.5x105) were seeded in duplicate on 100 mm plates coated with collagen I. 
The cells were then overlaid with 2% rBM diluted in growth media as specified 
above and media were changed on day four.  On day eight, media were switched 
to pH buffered DMEM/F12 containing 2% rBM for an additional incubation of 72 
hours. All cells, with the exception of the WS-12Ti fibroblasts, were harvested for 
RNA isolation in cold PBS with 5 mM EDTA.  The WS-12Ti fibroblasts were 
harvested with 0.1% collagenase.  RNA was isolated using an RNeasy Mini kit as 
described in manufacturer’s protocol from QIAGEN (Valencia, CA).  Total RNA 
quality was assessed and determined to be high quality as demonstrated by the 
absence of degradation products rRNA banding from the 26 and 19S.   
2.14 Microarray pathway analysis using biocomputational software 
 One technical replicate for each of the 12 conditions (six cell lines at both 
neutral and acidic pHe) described above (2.13) was applied to Affymetrix HG-
U133 plus two Arrays (AffyMetrix®; Santa Clara, CA).  Gene expression in the six 
cell lines (MCF10A, MCF10.DCIS, SUM 102, SUM 225, N1ME, and WS-12Ti) at 
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pHe 6.8 or 7.4. was determined at the H. Lee Moffitt Cancer Center and 
Research Institute, Florida. Commonalities among the six cell lines in gene 
expression changes induced by exposure to an acidic pHe were analyzed using:  
1) GeneGo MetaCore pathway analysis software (www.genego.com, St. Joseph, 
MI) at the Moffitt Cancer Center and 2) Genomatix (Genomatix Software GmbH, 
Munich, Germany) at the C.S. Mott Center for Human Growth & Development at 
Wayne State University.   
 A more thorough approach for bioinformatics analysis was designed in 
collaboration with the KCI Systems and Computational Biology core.   The 
original data from the Affymetrix HG-U133 plus two Arrays was used to perform 
the analysis. CEL files were used in a pair wise (pH 6.8 and pH 7.4) manner in 
GeneSpring (Agilent Technologies, Inc., Santa Clara, CA) to make normalized 
probe-level and gene-level experiments. SScore [(Kennedy et al., 2006) package 
http://home.att.net/~richard-kennedy/professional.html] was used to find 
differentially expressed probes from pair-wise (pH 6.8 and pH 7.4) CEL files at 
the significance=3.0 level (two-tailed p-value=0.003).  Probe-level experiments 
and R scripts (written by core group using R–R64- R.app GUI 1.34 (5589) 
x86_64-apple-darwin9.8.0) were used to perform quality analysis generating 
histograms and probe data files. Gene-level experiments generated full fold 
change files for the SScore probe lists and Venn diagrams and subsequently for 
making IPA Entrez gene ID uploads.  BioVenn (Hulsen et al., 2008) 
(http://www.cmbi.ru.nl/cdd/biovenn/) was used for comparisons of the three DCIS 
cell lines.  Using an SScore of 3, we identified 102 significantly changed Entrez 
	  	  
42	  
gene ids in the areas of overlap among the three DCIS cell lines.  The commonly 
grouped gene lists were examined with Ingenuity Pathway Analysis (IPA) core 
analysis software (Redwood City, CA). 
2.15 Statistical Analysis 
 Except where otherwise described, all experiments were analyzed using a 
two-tailed, unpaired Student’s T-test to determine statistical significance.   
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CHAPTER 3 
CONTRIBUTION OF CYSTEINE CATHEPSINS, 
INCLUDING CATHEPSIN B, TO PROTEOLYSIS 
3.1 Introduction 
Reprogramming of energy metabolism is one of two emerging cancer 
hallmarks recently added to the original six hallmarks of cancer (Hanahan and 
Weinberg, 2000; Hanahan and Weinberg, 2011).  Byproducts of elevated 
glycolytic activity result in an acidic extracellular pH (pHe) that is both 
heterogeneous and dynamic in solid tumors [for review, see (Gillies et al., 2002)]. 
Many cancer cells acquire acid-resistant phenotypes that allow them to survive 
and proliferate when the pHe is acidic (Gatenby et al., 2007; Wojtkowiak et al., 
2012) (Figure 1.4).  Acidification of the tumor microenvironment has been shown 
to increase invasiveness and metastasis.  The acid-mediated invasion 
hypothesis has been further described in chapter 1.4.  
One type of solid tumor that has an acidic pHe phenotype is breast 
cancer.  Breast cancer is a well-studied disease, but the diverse characteristics 
of the disease as a whole make it very complex and many challenges remain.  
The cell lines typically used can be genetically sub-categorized to allow one to 
delineate the diverse characteristics of primary tumors (Neve et al., 2006).  The 
molecular characteristics correspond to morphological characteristics observed 
by imaging cultures grown in 2D (Han et al., 2009) or 3D (Han et al., 2010; 
Kenny et al., 2007).  Clinically, triple negative breast cancer (TNBC) is 
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characterized by the lack of estrogen receptor (ER), progesterone receptor (PR) 
and (human epidermal growth factor receptor 2 (HER-2).  TNBC is the most 
difficult to treat because of the lack of targeted treatment options. At present 
TNBC is treated with chemotherapeutics and responses to those varies greatly 
among patients. TNBC has a shorter time to relapse and death and 
disproportionally affects African American women and younger women (for 
reviews of TNBC, see (Hudis and Gianni, 2011; Irvin and Carey, 2008)).  TNBC 
can be further sub-categorized into two basal-like (BL1 and BL2), an 
immunomodulatory (IM), a mesenchymal (M), a mesenchymal stem-like (MSL), 
and a luminal androgen receptor (LAR) subtypes. Comparative studies of these 
subtypes may help to design rational drug treatment strategies (Lehmann et al., 
2011).  I chose to focus my study on the most invasive types of breast cancer the 
TNBC MSL subtype. The MDA-MB-231 cells in 3D rBM overlay culture exhibit a 
stellate morphology characteristic of aggressive motile cancers (Han et al., 
2010).  MDA-MB-231 cells are the most commonly studied in this subtype of 
TNBC and thus would be a good cell line for comparison with the previous 
protease work in cells cultured at a neutral pH.  Using MDA-MB-231 xenografts, 
we buffered systemic and intratumoral pH in mice and showed that these 
treatments reduced spontaneous metastasis (Robey et al., 2009).  The systemic 
elevation in pHe is thought to reduce the activity of proteases that have an acidic 
pH optimum, such as cysteine cathepsins.   
Proteases, including cathepsin B, have been implicated in every stage of 
cancer progression from initiation and growth to metastasis (Edwards et al., 
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2008).  In order for a cancer cell to migrate away from the primary site, it has 
long been recognized that the basement membrane and extracellular matrix 
requires proteolytic modification.  Cysteine cathepsins participate in proteolytic 
networks that mediate cancer progression [for reviews, see (Mohamed and 
Sloane, 2006; Rothberg et al., 2012)].  As in vitro tissue culture experiments have 
been conducted at neutral pH, we now hypothesize that such analyses may have 
overemphasized the role of proteases that have neutral pH optima, such as the 
MMPs.  The acidic tumor microenvironment would favor the activity of proteases 
such as cysteine cathepsins that normally function at lysosomal pH, leading us to 
re-examine proteolysis and the proteases that are released and active at the 
acidic pHe surrounding solid tumors.  For these studies, we used a 3D rBM 
overlay model that provides a context for mechanisms critical to both mammary 
gland development and neoplastic processes, as has been described [for 
reviews, see (Debnath and Brugge, 2005; Weigelt and Bissell, 2008) also see 
chapter 1.3].  We are building on previous studies that have shown that an acidic 
pHe leads to lysosomal redistribution and secretion of cathepsin B in malignant 
cells (Rozhin et al., 1994).  Our study suggests that cathepsin B is active 
pericellularly and is one of the proteases that participates in the enhanced 
degradation of collagen IV observed at an acidic pHe.     
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3.2 Results 
3.2.1 Live-cell imaging of 3D rBM overlay cultures confirms presence of active 
proteases and proteolysis. 
To test our hypothesis that an acidic pHe enhances proteolytic activity and 
degradation of the basement membrane, we grew MDA-MB-231 in 3D rBM 
overlay cultures, following our previously described methods (Sameni et al., 
2012).  A quenched fluorescent form of the basement membrane protein type-IV 
collagen, i.e., DQ-collagen IV, was used to detect general proteolysis. The 
activity-based probe (ABP) GB123, which covalently binds to the active site 
(Blum et al., 2005), was used to detect active cysteine cathepsins.  We illustrate 
in Figure 2.3 live-cell imaging of degradation products of DQ-collagen-IV (A, C) 
and labeling of active cysteine cathepsins with GB123 (A, D) and nuclei with 
Hoescht 33342 (B) in MDA-MB-231 3D rBM overlay cultures.  We use this 
methodology to examine differences in DQ-collagen IV degradation and in active 
cysteine cathepsins, including their localization, at an acidic (6.8) as compared to 
a neutral (7.4) pHe. 
3.2.2 Acidic pHe enhances degradation of collagen IV.   
The acidic pHe of 6.8 was chosen as our test condition based on literature 
reports of the pHe in breast cancers and xenograft models (Gillies et al., 2002).  
In MDA-MB-231 3D rBM overlay cultures, we observed accumulation of 
degradation fragments of the basement membrane protein substrate at both pHe 
6.8 and 7.4 over a period of 3 days (Figure 3.1).  More extensive pericellular 
degradation products of DQ-collagen IV were apparent at pHe 6.8 (Figure 3.1, 
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right panels).  To better illustrate differences in degradation at the acidic pH, 
additional perspectives of the upper panels in Figure 3.1 can be viewed in 
Supplemental Movies 1 and 2.  This effect was verified in 3D cultures of a 
second triple negative breast cancer cell line, Hs578T, and also in HCT116 colon 
carcinoma cells.   HCT116 cells have previously been shown to acidify the tumor 
microenvironment similarly to MDA-MB-231 cells (Estrella et al., 2013).  The 
percentage increases in DQ-collagen IV degradation products, normalized to cell 
number, at pHe 6.8 for MDA-MB-231, Hs578T and HCT116 3D cultures are 
shown in Figure 3.2. There was a significant increase in DQ-collagen IV 
degradation products at the acidic pHe for MDA-MB-231 and HCT116 3D 
cultures and a trend towards increased DQ-collagen IV degradation products at 
the acidic pHe for Hs578T 3D cultures (p=0.10).  To rule out a direct effect of 
acidic pHe on degradation of DQ-collagen IV, coverslips coated with rBM were 
incubated as above, but without cells; there were no observable degradation 
products present at either acidic or neutral pH (Figure 3.3).   
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Figure 3.1. Degradation of DQ-collagen IV was greater at an acidic pHe.  Left 
(A, C and E) and right (B, D and F) panels depict 3-day cultures of MDA-MB-231 
cells grown in 3D rBM overlay cultures at pHe 7.4 and 6.8, respectively.  A and B 
represent the entire 3D volume showing cells (red), degradation products of DQ-
collagen IV (green) and nuclei (blue).  C and D represent degradation products of 
DQ-collagen IV in the entire 3D volume.  E and F represent intensity maps of the 
degradation products in C and D (white, most intense; violet, least intense).  
Images depicted represent the average fluorescent intensity of DQ-collagen IV 
degradation products per cell obtained in 14 to 15 images at the two pHs; bar, 
22.6 µm 
Figure 3.1 
A B 
C D 
E F 
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Figure 3.2. Quantification of DQ-collagen IV degradation products on a per 
cell basis for MDA-MB-231, Hs578T and HCT116 3D rBM overlay cultures.  
Values represent % increase at pHe 6.8 ( ) over pHe 7.4 controls (0% ± s.e.m); 
n ≥ 3 independent experiments with an average of 17 images analyzed per 
condition; ***, p ≤ 0.001. 
Figure'3.2'
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Figure 3.3.  In the absence of cells, degradation products (green 
fluorescence) could not be observed at either pHe 7.4 or 6.8.   
 
3.2.3 Human carcinoma cells exhibit an acid-resistant phenotype in 3D rBM 
overlay culture. 
To exclude possible effects of acidic pHe on proteolysis due to differences 
in proliferation and viability, we analyzed 3D rBM overlay cultures of the MDA-
MB-231, Hs578T, and HCT116 carcinoma cells for an acid-resistant phenotype.  
We did not observe any differences in proliferation, as assessed by Click-IT® 
EdU and MTT assays.  Nor was there a change in cellular viability as measured 
by a live/dead assay. Data are shown for MDA-MB-231 cells in Figure 3.4.  Thus 
under the conditions of our cultures, we establish that the MDA-MB-231, Hs578T 
(data not shown) and HCT116 (data not shown) carcinoma cells have an acid-
resistant phenotype.  
pH 7.4 pH 6.8 
13'
Figure 3.3 
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Figure 3.4.  MDA-MB-231 cells in 3D rBM overlay cultures exhibited similar 
proliferation and viability at pHe 7.4 (white bar) and 6.8 (gray bar), 
indicating an acid-resistant phenotype. Proliferation was assessed by two 
methodologies: A) EDU incorporation and B) MTT assays. Viability was 
assessed by: C) live/dead assays.  All data represent mean ± s.e.m.; n ≥ 3 
independent experiments performed in triplicate; p ≥ 0.05. 
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3.2.4 Acidic pHe increases pro and active cathepsin B. 
Previous studies on 2D cultures have demonstrated that an acidic pHe 
results in a peripheral distribution of cathepsin B intracellularly as well as 
cathepsin B secretion (Rozhin et al., 1994).  Similarly, in lysates of MDA-MB-231 
cells grown in 3D rBM overlay culture at pHe 6.8, cathepsin B activity was 
significantly increased (Figure 3.5 A; p = 0.046).  Secretion of procathepsin B 
(dextran sulfate-activated) was also significantly increased (p = 0.02), as 
assessed by assaying cathepsin B activity in the conditioned media (Figure 3.5 
B). Activity was eliminated by CA074, a highly selective cathepsin B inhibitor, 
confirming the specificity of the assay for cathepsin B (Murata et al., 1991).   
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Figure 3.5.  Cathepsin B activity was increased at acidic pHe.  MDA-MB-231 
cells were grown in 3D rBM overlay cultures at pHe 7.4 or 6.8 and then serum 
starved (0.2% FBS) for 24 hours in media buffered at either pH 7.4 or 6.8.  Cell 
lysates (A) and conditioned media (B) were analyzed for activity of cathepsin B 
and dextran sulfate activated pro-cathepsin B respectively, using, Z-Arg-Arg-
NHMEC. Activity was completely abrogated by 10 µM CA074 (I) versus vehicle 
control (V), thus confirming the specificity of the assay. Data were normalized to 
DNA and are scaled to activity at pH 7.4, designated as 100%; *, p ≤ 0.05. 
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3.2.5 Inhibition of cathepsin B decreases degradation of collagen-IV. 
To determine whether increased cathepsin B activity at pHe 6.8 
contributed to the enhanced degradation of DQ-collagen IV (Figure 3.1), we 
tested the ability of CA074, a highly selective cathepsin B inhibitor (Murata et al., 
1991), to affect that degradation.  At both pHe 7.4 and 6.8, inhibition of cathepsin 
B reduced the accumulation of degradation fragments of DQ-collagen IV (Figure 
3.6; also see Supplemental Movies 3 - 6). Proteolysis was significantly reduced, 
but not completely abrogated, by CA074 at both pHe 7.4 (Fig. 4E; p = 0.004) and 
6.8 (Fig. 4F; p = 1E-7).  The reduction in proteolysis at pHe 6.8 was 12% greater 
than at pHe 7.4, consistent with cathepsin B contributing to the enhanced 
degradation of DQ-collagen IV at pH 6.8.  The reduction in proteolysis in the 
presence of 20 µM CA074 was not due to cell death, as assessed by a live-dead 
assay (Figure 3.7). Our results suggest that cathepsin B as well as other 
proteases contribute to the degradation of the basement membrane protein 
collagen IV at both a neutral and acidic pHe. 
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Figure 3.6. Degradation of DQ-collagen IV was reduced by inhibition of 
cathepsin B.  MDA-MB-231 cells (red) were grown at pHe 7.4 (A, C) or 6.8 (B, 
D) in 3D rBM overlay cultures in the presence (C, D) or absence (A, B) of CA074.  
Degradation products of DQ-collagen IV (green) were present in DMSO vehicle 
controls (A, B) and reduced in the presence of the cathepsin B inhibitor (C, D).  
Images were chosen as ones representing the average fluorescent intensity of 
degradation products of DQ-collagen IV per cell (nuclei, blue); bar, 22.6 µm.  DQ-
collagen IV degradation products were quantified on a per cell basis in the entire 
3D volume for pHe 7.4 vehicle (V) and CA074 (I) (E) and 6.8 vehicle (V) and 
CA074 (I)  (F).  Values represent % of DMSO vehicle controls (100% ± s.e.m); n 
≥ 3 independent experiments with 13-19 images analyzed per condition; **, p ≤ 
0.01 and  ***, p ≤ 0.001.  
 
 
        
  
Figure 3.7.  Incubation with 20 µM CA074 (B) did not increase cell death as 
compared to that observed with DMSO (vehicle control, A) in 3D rBM 
overlay cultures of MDA-MB-231-RFP cells (red).  A live-dead assay was used 
to assess toxicity (absence of green).  Tiled images showing 12 fields of view 
were captured with a 20X lens; bar, 180 µm.  
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A B 
	  	  
57	  
3.2.6 At Acidic pHe GB123 is increased pericellularly. 
We have shown that we can visualize active cysteine cathepsins in 3D 
rBM overlay cultures of live breast carcinoma cells using ABPs that covalently 
bind to the active site of cysteine cathepsins B, L and S (e.g., see Figure 2.3). 
We observed a significant increase in bound GB123 at pHe 6.8 (cf. left with right 
images in Figures 3.8, 3.9, and 3.10, upper panels).  In normal cells, cysteine 
cathepsins are localized intracellularly in lysosomes; however, in tumor cells 
some cysteine cathepsins, e.g. cathepsin B, are lysosomal, secreted and bound 
to the cells surface (Mohamed and Sloane, 2006). We have previously shown 
that an acidic pHe increases the secretion and cell surface association of 
cathepsin B in malignant cells grown in monolayer culture (Rozhin et al., 1994).  
Here we determined whether pHe 6.8 altered distribution of cysteine cathepsins 
in our 3D rBM overlay cultures. We used image arithmetic in MetaMorph™, as 
described previously (Jedeszko et al., 2008), to quantify intracellular and 
extracellular fluorescence of bound GB123.  There was a significant increase in 
GB123 bound (i.e., active cysteine cathepsins) pericellularly at pHe 6.8 (cf. 
middle panels Figures 3.8, 3.9, and 3.10).   
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Figure 3.8. Total and pericellular active cysteine cathepsins in 3D rBM 
overlay cultures of MDA-MB-231 breast carcinoma cells were increased at 
pHe 6.8.  Active cysteine cathepsins were labeled, using GB123 (cyan), in the 
entire volume of 3D rBM overlay cultures of MDA-MB-231 cells (red) grown at pH 
7.4 (left panels) and pH 6.8 (right panels).  The amount of total bound GB123 is 
shown in upper panels (A, B), pericellular bound GB123 in the middle panels (C, 
D) and intracellular bound GB123 in the bottom panels (E, F).  Images depicted 
represent the average fluorescent intensity of bound GB123 per cell; bar, 22.6 
µm.  G) Graphs depict average fluorescent intensity of bound GB123 per cell ± 
s.e.m at pHe 7.4 ( ) and 6.8 ( ); n ≥ 3 independent experiments with an 
average of 26 images analyzed per condition; **, p ≤ 0.01 and ***, p ≤ 0.001.  
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Figure 3.9. Total and pericellular active cysteine cathepsins in 3D rBM 
overlay cultures of Hs578T breast carcinoma cells were increased at pHe 
6.8.  Active cysteine cathepsins were labeled, using GB123 (cyan), in the entire 
volume of 3D rBM overlay cultures of Hs578T cells (red) grown at pH 7.4 (left 
panels) and pH 6.8 (right panels).  The amount of total bound GB123 is shown in 
upper panels (A, B), pericellular bound GB123 in the middle panels (C, D) and 
intracellular bound GB123 in the bottom panels (E, F).  Images depicted 
represent the average fluorescent intensity of bound GB123 per cell; bar, 22.6 
µm.  G) Graphs depict average fluorescent intensity of bound GB123 per cell ± 
s.e.m at pHe 7.4 ( ) and 6.8 ( ); n ≥ 3 independent experiments with an 
average of 12 images analyzed per condition; ***, p ≤ 0.001.  
0 
2 
4 
6 
8 
1 
0 
2 
4 
6 
8 
1 
0 
2 
4 
6 
8 
1 
Figure 3.9 
Pericellular 
Intracellular 
[G
B
12
3 
S
ig
na
l /
 C
el
l] 
x 
10
8  
pHe 7.4 pHe 6.8 
Total 
*** 
*** 
Hs578T 
A B 
C D 
E F 
G 
	  	  
60	  
    
Figure 3.10 Total and pericellular active cysteine cathepsins in 3D rBM 
overlay cultures of HCT116 colon carcinoma cells were increased at pHe 
6.8.  Active cysteine cathepsins were labeled, using GB123 (cyan), in the entire 
volume of 3D rBM overlay cultures of HCT116 cells (red) grown at pH 7.4 (left 
panels) and pH 6.8 (right panels).  The amount of total bound GB123 is shown in 
upper panels (A, B), pericellular bound GB123 in the middle panels (C, D) and 
intracellular bound GB123 in the bottom panels (E, F).  Images depicted 
represent the average fluorescent intensity of bound GB123 per cell; bar, 22.6 
µm.  E) Graphs depict average fluorescent intensity of bound GB123 per cell ± 
s.e.m at pHe 7.4 ( ) and 6.8 ( ); n ≥ 3 independent experiments with 17 
images analyzed per condition; **, p ≤ 0.01 and ***, p ≤ 0.001.  
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As this is, to our knowledge, the first time that GB123 has been used to 
detect active cysteine cathepsins pericellularly, we employed the broad-spectrum 
cysteine protease inhibitor, E64, to confirm that the bound GB123 was detecting 
active cysteine proteases pericellularly.  At pHe 6.8 we again observed 
significantly greater total and pericellular bound GB123 (cf. Fig. 3.11B with Fig. 
3.11A).  Pericellular bound GB123 was adjacent to the cells, consistent with the 
known membrane association of cysteine cathepsins in tumors (Mohamed and 
Sloane, 2006) and with the removal of active non-cell associated cysteine 
cathepsins bound to GB123 by washing.  The increase in bound GB123 at pHe 
6.8 was reduced by E64, confirming that GB123 was detecting active cysteine 
proteases.  To determine which of the cysteine cathepsins known to be detected 
by GB123 (Blum et al., 2005) were present in our 3D rBM overlay cultures, we 
subjected cell lysates to immunoprecipitation using antibodies to cathepsins B, L 
and S.  We detected binding of GB123 to cathepsin B and cathepsin L, but were 
unable to detect binding of GB123 to cathepsin S (Figure 3.12). To confirm an 
absence of cathepsin S, serial immunoprecipitations (Figures 3.13 and 3.14) 
were performed using a different cathepsin S antibody.  A signals were observed 
at about 31-kDa, the molecular weight as cathepsin B, rather than 28-kDa as 
expected for active cathepsin S (Figures 3.13 and 3.14).  These results would be 
consistent with the active cysteine cathepsins detected by GB123 in the 3D 
cultures at an acidic pHe being cathepsins B and L. 
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Figure 3.11. Pericellular bound GB123 was reduced by E64, a broad-
spectrum inhibitor of cysteine proteases.  Active cysteine cathepsins were 
labeled, using GB123 (cyan), in the entire 3D volumes of 3D rBM overlay 
cultures of MDA-MB-231 cells (red) grown at pHe 7.4 (A, C) or 6.8 (B, D).   Upper 
(A, B) and lower (C, D) images represent vehicle (DMSO) controls and E64, 
respectively.  Images depicted represent the average intensity of pericellular 
bound GB123/cell; bar, 22.6 µm.  E) Graph illustrates average integrated 
intensity ± s.e.m of total, pericellular and intracellular bound GB123 at pHe 7.4 
vehicle ( ) and E64 ( ) and pHe 6.8 vehicle ( ) and E64 ( ); n ≥ 3 
independent experiments with an average of 19 images analyzed per condition.  
Analysis of variance was used to determine significance; ***, p ≤ 0.001. 
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Figure 3.12. Active cysteine cathepsins in MDA-MB-231 cells were profiled 
by in-gel fluorescence with the ABP GB123. Signals for GB123-bound 
cathepsin B and L were identified by immunoprecipitation. Signals are 
shown pseudocolored in red to represent the far-red emission of Cy5 (top panel) 
and in an inverted gray scale (bottom panel).  Signals represent covalent binding 
of GB123 to the active site of cysteine cathepsins in lysates of 3D rBM overlay 
cultures of the MDA-MB-231 cells.  Lanes represent: supernatants after 
immunoprecipitation with either preimmune IgG (lane 2) or antibodies to 
cathepsin B (lane 4), S (lane 6) or L (lane 8) or pellets after immunoprecipitation 
with either preimmune IgG (lane 3) or antibodies to cathepsin B (lane 5), S (lane 
7) or L (lane 9); or molecular weight markers (lanes 1 and 10).  Figure 3.12 
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Figure 3.13. Active cysteine cathepsins B and L in MDA-MB-231 cells were 
identified by sequential immunoprecipitation with antibodies to cathepsins 
L, B and S.  Signals represent GB123-bound active cysteine cathepsins in 
lysates of 3D rBM overlay cultures of the MDA-MB-231 cells. Lanes represent 
total cell lysate (lane 2), supernatant after serial immunoprecipitation with 
antibodies to cathepsin L, B and S (lane 6) and pellet after immunoprecipitation 
with antibodies to cathepsin L (lane 3), B (lane 4) or S (lane 5); or molecular 
weight markers (lanes 1 and 7).  
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Figure 3.14. Absence of GB123-bound cathepsin S in MDA-MB-231 cells 
was confirmed by sequential Immunoprecipitation with antibodies to 
cathepsins S, B and L. Signals represent covalent binding of GB123 to the 
active site of cysteine cathepsins. Lanes represent supernatants after 
immunoprecipitation with normal goat serum (lane 2) or preimmune IgG (lane 4) 
or after serial immunoprecipitation with antibodies to cathepsin S, B and L (lane 
9); pellets after immunoprecipitation with normal goat serum (lane 3), preimmune 
IgG (lane 5) or antibodies to cathepsin S (lane 6), B (lane 7) or L (lane 8); or 
molecular weight markers (lanes 1 and 10).   
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3.2.7  GB123 is detected in tumors in vivo   
Our previous studies have show that, without affecting systemic pH, 
imbibement of sodium bicarbonate is able to neutralize intertumoral pHe and 
reduce spontaneous metastasis (Robey et al., 2009).  To test our hypothesis that 
the acidic tumor microenvironment enhances cysteine cathepsin activity in vivo, 
we measured GB123 intensity values in acidic or bicarbonate neutralized 
orthotopic MDA-MB-231 tumors (Figures 3.15 and 3.16A).  The cohort sample 
was small and in addition one of the tumors in a bicarbonate treated mouse 
became severely ulcerated and could not be used for this analysis.   Nonetheless 
despite the small sample size, there was a significant decrease in bound GB123 
with sodium bicarbonate imbibement (Figure 3.16B).  Correlating with an 
expected more acidic pHe in the control group, There was a decrease in viable 
tissue in the control group due to the combination of acidosis and hypoxia (Figure 
3.18), whereas there was not a significant change in the amount of hypoxia 
(Figure 3.16C and D).  Our results demonstrate the increased activity of 
cathepsin B and other cysteine cathepsins in an acidic environment in vitro and 
in vivo.   
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Figure 3.15.  GB123 localizes to orthotopic MDA-MB-231 tumors in vivo, 
indicating that active cysteine cathepsins are present in these tumors.  
Images represent fluorescence of GB123 retained 18 hours post-injection 
overlaid on tumor-bearing mice. 
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Figure 3.16. In vivo buffering of tumor pHe reduced tumor binding of 
GB123. A) Enlarged representative fluorescent images, from the six shown in 
Figure 3.15, of MDA-MB-231 orthotopic tumors showing retention of GB123 18 
hours post-injection.  B) Average normalized counts of GB123 retained in MDA-
MB-231 orthotopic tumors ± s.e.m; a one-tailed, unpaired T-test was used to 
determine significance, p = 0.03.  C) Representative images of positive pixel 
analysis of viable stained tissue illustrating intensity of pimonidazole staining: 
blue is negative staining, orange is moderate staining, red is strong positive 
staining, and gray is non-viable tissue. Inset shows immunohistochemistry of 
pimonidazole staining used for analysis.  Size markers in both are equal to 1 mm.  
D) Quantification of pimonidazole staining in FFPE tumors, reported as number 
of strong positive pixels / number of pixels of viable tissue ± s.e.m; p = 0.086. 
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Figure 3.17. Segmentation of viable tissue.  A) Representative IHC staining of 
pimonidazole in orthotopic MDA-MB-231 tumors from mice given tap water or 
water containing sodium bicarbonate to drink.  B) Computational segmentation of 
viable (green) and non-viable tissue (pink).  C) Positive pixel analysis of 
segmented viable tissue showing intensity of pimonidazole staining: blue 
indicates negative staining, orange moderate staining and red strong staining. 
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3.3 Discussion 
The acid-mediated invasion hypothesis is supported by a large quantity of 
correlative data described in chapter 1.4.  This increase in active proteases may 
enhance invasion since in cancer xenografts invasion has been shown to occur 
more often in regions where the pHe is acidic (Estrella et al., 2013).  The 
possibility that cysteine cathepsins facilitate acid-mediated invasion is supported 
by prior work demonstrating that acid pHe induces redistribution of endosomes 
and lysosomes to the cell surface and increases release of cysteine cathepsins 
(Glunde et al., 2003; Rozhin et al., 1994; Steffan et al., 2009).  In MCF10A, a 
diploid mammary epithelial cell, exposed to an acidic pH for one hr show a 
redistribution of cathepsin B towards the membrane periphery, while the 
transformed MFC10neoT cells increased the release of cathepsin B (Rozhin et 
al., 1994).  Lysosomal movement to cell periphery in response to pHe was also 
observed in breast cell lines of varying malignancy including the MDA-MB-231 
cells (Glunde et al., 2003).  Additionally, this study noted the decrease in number 
of lysosomes at the slightly acidic pH of 6.8, suggesting that they might be 
exocytosed, such as what is observed with cathepsin B and the more the 
malignant cell lines had larger vesicles reminiscent of macroautophagy, although 
neither aspect was examined in these studies.   
The redistribution of cathepsin B, endosomes, and lysosomes towards the 
cell periphery is microtubuial dependent process (Heuser, 1989; Matteoni and 
Kreis, 1987; Rozhin et al., 1994).  In addition to pH-dependent relocation and 
exocytosis, additional roles for lysosomes and the cell periphery have been 
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illuminated such as the Ca-dependent exocytosis observed in both non-secretory 
cells and as a function of mammalian plasma membrane repair (Andrews, 2002; 
Jaiswal et al., 2002; Reddy et al., 2001). Macrophages and fibroblasts also 
exhibit redistribution of endosomes and lysosomes towards the cell periphery in 
response to slightly acidic pH (Heuser, 1989), suggesting this might be an 
universal cellular response, In our study we observed cysteine cathepsins at the 
cell periphery and extracellularly in cells cultured at pH 6.8 in two invasive breast 
cancer cell lines (Figures 3.8 and 3.9) as well as in a colon carcinoma cell line 
(Figure 3.10), and previously in breast, colon, and melanoma cell lines of higher 
malignancy (Rozhin et al., 1994) suggesting our results are applicable in other 
aggressive solid tumors.  
In the current work, we show using selective labeling with ABPs and 
inhibitors that cysteine cathepsins, notably cathepsin B, are involved in the acid-
mediated degradation of the basement membrane protein type-IV collagen, 
which is integral to acid-mediated invasion.  This study shows for the first time 
detection of pericellularly ABP-bound cysteine cathepsins in the highly malignant 
cells (Figures 3.8, 3.9, 3.10). This may reflect: 1) the extensive invasive 
processes on these cells, processes with a large surface area for the binding of 
membrane-associated cysteine cathepsins such as cathepsin B (Mohamed and 
Sloane, 2006); 2) the acid resistant-phenotype of these cells; and 3) retention 
pericellularly of secreted cysteine cathepsins by the matrix used for the 3D rBM 
overlay cultures. 
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The exact effects of acidic pHe are still unknown.  As the invasive cancer 
cells are acid-resistant (Figure 3.5) and can maintain a neutral intracellular pH 
even in the face of low pHe, we do not suspect that the response to an acidic 
pHe is transduced through a lowering of cytosolic pH.  In fact, there are many 
studies confirm that the intracellular pH remains in the normal range (Gerweck 
and Seetharaman, 1996; Hulikova et al., 2012; McCarty and Whitaker, 2010; 
Wojtkowiak et al., 2011; Zhang et al., 2010).  Rather we hypothesize that there is 
an increase in fusion of secretory lysosomes with the plasma membrane and 
release of their contents.  One of the classic examples of cells that contain 
secretory lysosomes is the osteoclast (Andrews, 2000).  At the site of bone 
degradation, osteoclasts generate resorption lacunae that become highly 
acidified (pHe ~ 4.7) via fusion of lysosomes with the plasma membrane.  This is 
a result of insertion of lysosomal vacuolar H+-ATPases into the plasma 
membrane and is accompanied by release of cathepsin K, a cysteine protease 
essential for bone degradation (Saftig et al., 1998).  In MDA-MB-231 breast 
cancer cells, vacuolar H+-ATPases are highly expressed on the cell surface and 
are linked to their invasiveness (Sennoune et al., 2004). 
Recently, a number of acid-stimulated ion channels (ASICs) have been 
identified, which can transduce acidic pHe through IP3/PI3K pathways and 
increase calcium and cAMP signaling (Brown and Wagner, 2012; Chu et al., 
2011).  Interestingly, metastatic cancer-associated bone pain, including in breast 
cancer, has been linked to signaling through ASICs; in this case the ASICs are 
on neurons that innervate bone and respond to the acidic pHe produced by 
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osteoclasts involved in bone resorption by the metastatic cancer cells (Yoneda et 
al., 2011).  ASICs are part of the superfamily of ENaC/degenerin cation 
channels.  ASICs and ENaCs are regulated by proteolysis, including by 
membrane anchored serine proteases (Clark et al., 2010; Kota et al., 2012).  
ENaCs are also regulated by cysteine cathepsins, specifically by cathepsins B 
and S (Alli et al., 2012; Haerteis et al., 2012). Neither regulation of ASICs by 
cysteine cathepsins or regulation of both ENaCs and ASICs by cysteine 
cathepsins has been studied in cancer cells to our knowledge.  Additionally, MSL 
subtypes of TNBC have an enrichment of calcium signaling and RHO canonical 
pathways (Lehmann et al., 2011).  Cardelli and colleagues have shown in 
prostate cancer cells that an acidic pHe initiates lysosomal trafficking to the 
plasma membrane, cathepsin B secretion and increased invasion dependent on 
microtubules, RhoA and PI3K (Steffan et al., 2009).  Based on this series of 
observations and the current work, we propose a model wherein extracellular 
acidosis is transduced via ASICs into a signal impinging on the PI3K pathway, 
microtubules and RhoA to promote the redistribution of lysosomes leading to the 
release of cathepsin B and other proteases at the acidic and invasive edges of 
the tumors.   
In accordance with the acid-mediated invasion hypothesis, the present 
study and other studies have shown that an acidic pHe increases expression and 
activity of matrix-degrading proteases such as the cysteine cathepsins B and L 
and MMP-2 and -9 (Rothberg et al., 2012).  Cathepsin B secreted through 
microvesicles or exosomes has (Cavanaugh et al., 1983) been reported at acidic 
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pHe to induce greater activation of latent MMPs and to potentiate endothelial cell 
invasion and angiogenesis (Giusti et al., 2008; Taraboletti et al., 2006).  In the 
current study, we have shown a dramatic increase in general proteolysis at acidic 
pHe (Figures 3.2 and 3.3), consistent with participation of multiple proteases in 
the proteolysis at the acidic pHe.  Resistance of tumor cells weakly basic 
chemotherapeutics is increased in vitro by an acidic pHe (Jahde et al., 1990) and 
the effectiveness of chemotherapy in mouse models is reduced by the cysteine 
cathepsins B and S secreted by tumor-associated macrophages (Shree et al., 
2011).  These studies suggest that chemotherapy in combination with an agent 
that increases pHe and thereby indirectly reduces cysteine cathepsin activity or 
one that directly inhibits cysteine cathepsin activity could be beneficial in the 
clinic.  Indeed, we have shown in mouse models that tap water supplemented 
with sodium bicarbonate, a systemic alkalizing buffer that increases pHe, 
decreases metastasis (Robey et al., 2009) and improves response to 
chemotherapy (Raghunand et al., 1999).  Sodium bicarbonate treatments to 
neutralize the acidic pHe have been investigated in phase I/IIa trials for bone 
pain (NCT01350583) and in combination with gemcitabine for unresectable 
pancreatic cancer (NCT01198821).  Both of these trials have closed, and are 
scheduled to re-open as new trials pending reformulation (RJ Gillies, personal 
communication). 
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CHAPTER 4 
ELEVATED STAT1 SIGNALING IN DCIS CELL LINES 
REVEALED BY MICROARRAY ANALYSIS 
4.1  Introduction  
Breast cancer continues to be the most commonly diagnosed cancer in 
women. In 2012, 29% of all new cancer diagnoses were breast cancer. The 
disease has a high mortality rate (14%), second only to lung cancer (26%).  The 
American Cancer Society also predicts that, in addition to the 230,480 new cases 
of breast cancer, an additional 57,650 new diagnoses of ductal carcinoma in situ 
(DCIS) for 2011.  We are interested in forces including those in the 
microenvironment that drive breast cancer progression from normal to pre-
malignant to invasive.   
Breast cancer remains the most commonly diagnosed cancer in women 
(30% or 230,480 new cases predicted for 2011) and has a high mortality rate, 
second only to lung cancer.  The American Cancer Society predicted that in 
addition to the 230,480 new cases of breast cancer there would be 57,650 new 
diagnoses of DCIS predicted for 2011.  DCIS incidence has dramatically 
increased, mostly but not solely due to advances in standard mammographic 
screening. DCIS accounts for 20% of newly diagnosed breast cancer today. A 
DCIS diagnosis can range from a non-invasive low-grade lesion to a high-grade 
comedo type, which is associated with increased risk for subsequent 
development of invasive cancer (Miller et al., 2001).  A recent study shows that 
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women with DCIS who have reoccurrence of invasive cancer after lumpectomy in 
the ipsilateral breast are at an increased risk of mortality, which can be 
significantly reduced by adjuvant radiation and tamoxifen (Wapnir et al., 2011). 
This increased risk of mortality unfortunately translates into overtreatment for the 
95% of women diagnosed with DCIS whose disease will most likely not progress.   
Our laboratory has a long-standing interest in the contribution of the tumor 
microenvironment to the progression of breast cancer (Moin et al., 2012; 
Rothberg et al., 2012; Sloane et al., 2005).  There are many aspects of the 
breast tumor microenvironment to consider such as surrounding stromal cells 
(e.g., fibroblasts and macrophages), normal non-transformed epithelial cells, as 
well as non-cellular aspects such as the matrix composition and pH.  Previous 
studies in our laboratory as well as studies by others indicate that tumor-
associated fibroblasts increase proteolysis and invasive characteristics of breast 
tumor cells (Moin et al., 2012; Rothberg et al., 2012; Sameni et al., 2009; Sameni 
et al., 2003), whereas the myoepithelial cells decrease the invasive 
characteristics of the breast cancer cells (Barsky and Karlin, 2006; Holliday et al., 
2009; Hu et al., 2008; Pandey et al., 2010).  Our collaborator Dr. Robert J. Gillies 
and his group at the Moffitt Cancer Center have a long-standing interest in 
understanding the effects of an acidic extracellular microenvironment [for reviews 
see (Gillies et al., 2002; van Sluis et al., 1999; Wojtkowiak et al., 2011)].   In a 
joint effort with the Gillies laboratory, we are trying to isolate markers that can 
identify an acidic pHe as a result of the actively metabolizing DCIS lesions.   Our 
hypothesis is that the breast microenvironment cells will have a common 
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response to an acidic pHe and lead to the progression of DCIS pre-invasive 
lesions, i.e., cancer poised to become invasive (Figure 1.5).  As there are not at 
present any selective biomarkers for an acidic tumor microenvironment, 
surrogate biomarkers are used such as carbonic anhydrase, pimonidazole and/or 
GLUT1 (Wojtkowiak et al., 2012).  Carbonic anhydrase and pimonidazole are 
commonly used markers for hypoxia/acidosis and GLUT1 is used as a marker of 
a high glycolytic phenotype.  In addition to discovering biomarkers for an acidic 
pHe, we hope to identify pathways by which an acidic pHe may influence DCIS 
progression to invasive carcinoma. 
Our laboratory has a variety of breast cell lines (Figure 2.1).  The MCF10A 
progression series is a human breast model cellular system developed by Dr. 
Fred Miller of Karmanos.  The MCF10A is a diploid line that spontaneously 
immortalized from a population of cell isolates from a patient with fibrocystic 
breast disease who underwent a reduction mammoplasty (Soule et al., 1990).  A 
series of isogenic cell lines have been derived after serial passaging in vivo of 
10A cells with a stable transfection of T24 H-Ras (Dawson et al., 1996; Miller et 
al., 1993).  The isogenic cell lines (10A, AT1, AT3B, DCIS, and Ca1D) represent 
normal, non-invasive, pre-invasive, and invasive phenotypes in vivo (Miller et al., 
2000; Miller et al., 2001; Santner et al., 2001) and our laboratory has 
demonstrated these phenotypes in 3D cultures ((Sameni et al., 2009) and 
reviewed in (Sameni et al., 2013)).  Both SUM-102 and -225 are patient-derived 
DCIS cell lines that were established in the Ethier laboratory [(Forozan et al., 
1999; Sartor et al., 1997) and (S. Ethier, MUSC, personal communication)].  
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SUM102 has low take rate efficiency (less than half) in establishing palpable 
tumors in immunodeficient mouse models. This can be enhanced if the SUM102 
cells are mixed with tumor-associated fibroblasts before implantation (Eck et al., 
2009).  The MCF10.DCIS line is pre-invasive, yet more than half of xenografts 
progress to invasive carcinomas after 9 weeks in vivo (Miller et al., 2000).  The 
SUM225 line has DCIS characteristics, but is actually a chest wall re-occurrence 
from a breast carcinoma (Behbod et al., 2009; Neve et al., 2006; Yang et al., 
2004).  The myoepithelial cell line, N1ME, is derived from primary human breast 
myoepithelial cells that were immortalized by transduction with MSCV-puro-
hTERT (Hu et al., 2008) and K. Polyak, Dana Farber, personal communication).  
WS-12Ti is an immortalized breast cancer-associated fibroblast line (Pauley et 
al., 2000).  
With the understanding that there are several types of cells in the breast, 
the Gillies laboratory designed a study to look at genomic expression differences 
as a result of exposure to an acidic pHe.  Gene expression analyses, using an 
Affymetrix GeneChip HG U133 Plus 2.0 Array, were performed for 6 human 
breast cell lines grown in 3D rBM overlay cultures at either a neutral or an acidic 
pHe.  The 6 breast cells are: MCF10A, MCF10.DCIS, SUM 102, SUM 225, WS-
12Ti, and N1ME.  Results from the microarray study were used to identify a 
transcriptional signaling pathway response to acidic pHe that may influence DCIS 
progression.   
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4.2 Results and Discussion  
4.2.1 Microarray data collection 
Although more thoroughly described in Methods Chapter 2, for this study 
six cell lines were grown in 3D rBM overlay cultures for 8 days in their respective 
growth media and then changed to media buffered to maintain a pH of either 6.8 
or 7.4 for 3 days.  The cells were harvested and total RNA isolated.  The RNA 
was analyzed using an Affymetrix GeneChip Array.  From the initial data analysis 
an excel file {acidic_response1(1).xls} was generated with results for 29,486 
genes that were altered at the acidic pHe among the 6 cell lines (provided as a 
supplemental file).  Data collected includes gene information (Entrez ID, symbol, 
description, unigene IDs, and probe ID(s) for each of these genes), a fluorescent 
output signal, fold change, and p-value for each gene significantly changed at 
slightly acidic as compared to neutral pH for each of the individual cell lines as 
well as an average of all six cell lines.  
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4.2.2 Parsing microarray data 
From this initial data collection, we identified ≥500 genes whose 
expression was altered in a minimum of four out of the six cell lines and had an 
average fold change of at least 1.2 between the cells exposed to a pHe of 6.8 
and 7.4.  Listed in Table 4.1 is a small subset of genes that are upregulated and 
of interest to ongoing projects in the Sloane and Gillies laboratories.  Dr. 
Wojtkowiak of the Gillies laboratory followed up on the upregulation of ATG5, 
which is an autophagic protein that assists in maturation of developing 
autophagophores. Wojtkowiak et al. (2012) hypothesized that autophagy has a 
role in mediating survival responses in cells conditioned for survival and growth 
at pH.  The elevation of cathepsin B in 4 of the 6 cell lines is in agreement with 
proteomic analyses that found elevated cathepsin B and its cell surface binding 
partner annexin II in ductal carcinoma in situ breast tissue as compared to 
matched controls (Wulfkuhle et al., 2002).  Those results provided a rationale for 
my studies on cathepsin B and proteolysis at an acidic pHe, which I describe 
further in chapter 3.  
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Table 4.1. Selected genes increased in expression at pHe 6.8 in at least 4 
out of 6 cell lines. Genes are shown here in order of fold change from > 3.0 
(cyan), >1.5 (light blue), and > 1.2.   
 
 
 
 
Gene 
Symbol Gene Description 
Average 
FC 
Score out 
of 6 cell 
lines 
NEBL Nebulette 7.09 4 
DLC1 Deleted in liver cancer 1 5.76 5 
DCAKD Dephospho-CoA kinase  4.01 4 
PPP1R1B Protein phosphatase 1 3.14 4 
ANXA11 Annexin A11 2.46 4 
IL32 Interleukin 32 2.26 4 
S100P S100 calcium binding protein P 1.93 5 
TIMP3 Tissue inhibitor of 
metalloproteinase 3 1.61 4 
ATG5 ATG5 autophagy related 5  1.58 4 
ARHGAP5 Rho GTPase activating protein 5 1.52 5 
CTSB Cathepsin B 1.43 5 
SOD2 Superoxide dismutase 2 1.36 4 
ALDH1A3 Aldehyde dehydrogenase 1  1.27 4 
Table 4.1.  
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4.2.3 Commonly upregulated genes 
Using the excel sheet {acidic_response1(1).xls} I performed a systematic 
search for genes upregulated 1.5 fold or greater at the acidic pH for each cell 
line. There were no commonly upregulated genes among the 6 cell lines at this 
cutoff value.  There were 6 common Entrez gene IDs among the 3 DCIS cell 
lines, but only 4 corresponded to validated genes. Those genes are interferon-
induced protein 35 (IFI35), endoplasmic reticulum aminopeptidase 1 (ERAP1), 
oliogadenylate synthase 1 (OAS1), and a catalytic subunit of DNA polymerase 1 
(POL1).  To determine if these genes were connected, I used Genomatix 
Pathway System software. The pathway system module will statistically 
associate user-input data with verified regulatory pathway information based on 
literature for genes, proteins and their interactions.   The analysis was performed 
and several biological processes (Table 4.2), molecular functions (Table 4.3), 
and 3 diseases (Table 4.4) were found.    
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Table 4.2. Top Gene Ontology biological processes, as determined by 
Genomatix, for the commonly elevated genes among the three DCIS cell 
lines at pHe 6.8.  Genes with a minimum average fold change > 1.5 were 
considered. 
 
 
GO-Term P-value 
# 
Genes 
(total) 
List of observed 
genes 
immune response 5.11E-04 736 IFI35, ERAP1, OAS1 
immune system process 1.64E-03 1094 IFI35, ERAP1, OAS1 
antigen processing and 
presentation of endogenous 
peptide antigen via MHC 
class I 
1.67E-03 6 ERAP1 
antigen processing and 
presentation of endogenous 
peptide antigen 
1.67E-03 6 ERAP1 
antigen processing and 
presentation of endogenous 
antigen 
2.23E-03 8 ERAP1 
response to other organism 3.91E-03 373 IFI35, ERAP1 
response to stimulus 4.49E-03 3713 IFI35, ERAP1,        OAS1, POLI 
antigen processing and 
presentation of peptide 
antigen via MHC class I 
5.01E-03 18 ERAP1 
response to biotic stimulus 6.10E-03 468 IFI35, ERAP1 
antigen processing and 
presentation of peptide 
antigen 
7.23E-03 26 ERAP1 
membrane protein 
ectodomain proteolysis 7.51E-03 27 ERAP1 
membrane protein proteolysis 8.90E-03 32 ERAP1 
Table 4.2.  
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Table 4.3. Top Gene Ontology molecular functions, as determined by 
Genomatix, for the commonly elevated genes among the three DCIS cell 
lines at pHe 6.8.  Genes with a minimum average fold change > 1.5 were 
considered. 
 
 
 
 
 
 
GO-Term P-value # Genes (total) 
List of observed 
genes 
nucleotidyltransferase activity 3.56E-04 120 OAS1, POLI 
interleukin-6 receptor binding 1.55E-03 6 ERAP1 
interleukin-1 receptor binding 2.85E-03 11 ERAP1 
aminopeptidase activity 8.01E-03 31 ERAP1 
DNA-directed DNA polymerase 
activity 8.27E-03 32 POLI 
DNA polymerase activity 9.55E-03 37 POLI 
metalloexopeptidase activity 9.81E-03 38 ERAP1 
Table 4.3.  
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Table 4.4 Significant diseases, as determined by Genomatix, for the 
commonly elevated genes among the three DCIS cell lines at pHe 6.8.  
Genes with a minimum average fold change > 1.5 were considered. 
 
 
 
 
 
 
 
 
 
MeSH-Term P-value # Genes (total) List of observed genes 
Carcinoma, Basal Cell 3.72E-04 710 IFI35, ERAP1, OAS1    
Neoplasms, Basal Cell 4.44E-04 754 IFI35, ERAP1, OAS1 
Bowen's Disease 7.75E-04 177 IFI35, OAS1 
Table 4.4  
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Genomatix like other pathway analysis software (Ingenuity IPA, or 
GeneGo) uses published literature systematically mined by computer and hand 
(human) curations to establish a biological context for genes and proteins.  
Because of the vast differences in terminology across fields and disciplines, 
Open Biological and Biomedical Ontologies, a website foundry, has established 
organizational systems for classification of biomedical terms (Smith et al., 2007).  
Gene Ontology is one of these, which focuses on the vocabulary of genes, their 
products and annotations.  Gene Ontology classifies the genes into 3 domains: 
1) Cellular component---where the products are located in relation to 
the cell as a whole, organelles of a eukaryotic cell, or protein complex  
2) Molecular function---the gene product function or activity (e.g., 
binding, or transporter activity) or role played in a more specific cellular 
activity (e.g., interleukin-6 receptor binding), 
3) Biological process---series of events of at least one or more distinct 
steps or a succession of molecular functions typically with a start and 
end, but does not discriminate dynamics or dependencies that would be 
encompassed in a pathway (Ashburner et al., 2000). 
Genomatix pathway analysis software used Gene Ontology terms to classify my 
list of genes that were commonly elevated at an acidic pHe to both biological 
processes (Table 4.2) and their molecular functions (Table 4.3).  Similarly the 
software used Medical Subject Headings (MeSH) (Rogers, 1963) as the classifier 
for diseases (Table 4.4).   
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Three of the four upregulated genes (ERAP1, IFI35 and OAS1) modulate 
immune responses (Table 4.2) and are associated with the MeSH term “basal-
cell” cancers (Table 4.4).  ERAP1 plays a central role in peptide trimming in the 
ER, allowing peptides to be loaded into major histocompatibility complex (MHC) 
class-1 molecules for self-recognition by the immune system (Chang et al., 
2005).  Interestingly, ERAP1 is also required for interleukin 6 receptor (IL-6R) 
shedding (Cui et al., 2003). Shedding can lead to signal amplification, prolonged 
half-life and allows IL-6 signaling in cells not expressing IL-6R (Jones et al., 
1999; Marin et al., 2002; Peters et al., 1996).  Following activation by IL-6, 
downstream signaling leads to activation of  
(STAT) family members 1 and 3 (Gerhartz et al., 1996).   STAT1 signaling 
can increase IFI35 transcription.  IFI35 is a leucine zipper protein that is 
translocated from cytoplasmic aggregates into the nucleus following interferon 
treatment, but IFI35 does not mediate transcription despite the common 
transcription factor motiff (Bange et al., 1994).  OAS1 is a member of the 2-5A 
synthetase family, which is most well known for mediating the innate immune 
response to viral infections following interferon signaling.   
The transcript signals from the microarrays original read were additionally 
analyzed with 2 separate pathway analysis tools.  The software platforms 
perform enrichment analysis to identify relevant canonical pathways, networks, 
and Gene Ontology classifications.  The Gillies laboratory used GeneGo 
MetaCore pathway analysis software to look for commonalties among all 6 cell 
lines and we, with the collaboration of the Systems and Computational Biology 
	  	  
89	  
Core, used Ingenuity Pathway Analysis (IPA) to identify common responses 
among the three DCIS cell lines (see below). 
4.2.4    Unique rigorous examination using IPA pathway analysis 
4.2.4.1  SScore 
Instead of using the excel file, I took the data collected from arrays (i.e., 
original CHP, CEL and RPT files) to the Systems and Computational Biology 
Core at Karmanos.   We performed an analytical workflow to allow extraction of 
high confidence results from the Moffitt-designed single replicate microarrays for 
the 6 cell lines.  To do this in the absence of true technical replicates, we took 
advantage of the 20 pairs of matched probes for each gene on the Affymetrix 
chip and used this internal chip data to estimate an error model for the gene 
expression differences via SScore (significance score) analysis.  "SScore offers 
high sensitivity without loss of specificity in detecting differentially expressed 
genes. The SScore produces accurate results even when few or no replicates 
are available” (Kennedy et al., 2006).  SScore is designed to compare gene 
expression of Affymetrix genechips using probe pair signal intensities that take 
into account background noise levels in order to determine significant differences 
in gene expression.  The SScore analysis outputs a standard normal distribution 
centered around zero or no change in expression and thus p-values can easily 
be determined.  In our case the SScore was used to determine if the probe pairs 
average had a statistically significant chance of being "real changes" in terms of 
the chip hybridization observed at the acidic as compared to the neutral pHe. 
Three SScore values were considered: 3, 2.5 and 1.96, each corresponding with 
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a predictive percentage of real change of 99.7%, 99%, and 95%, respectively.  
The most stringent SScore of 3 (two-tailed, p-value=0.003) was chosen as an 
appropriate cut-off for selection of genes for further analysis. The numbers of 
probes and genes in all six cell lines that were identified with this SScore cut-off 
are displayed in Table 4.5.  
 
Table 4.5. Probes and corresponding genes changed at pHe 6.8 in each of 
six cell lines. Probes represent ones changed, using an SScore of three.   
 
 
 
 
 
 
Table 4.5 
Cell Lines Probe Count at  SScore of 3 
RefSeq Genes 
Represented 
MCF-10A 652 440 
MCF10.DCIS 549 320 
SUM 102 969 713 
SUM 225 618 474 
N1ME 972 664 
WS-12Ti 982 689 
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4.2.4.2 Genespring quality controls 
The Systems and Computational Biology Core simultaneously matched 
probe data from Affymetrix .CEL files to an Entrez ID in GeneSpring and 
normalized the data to internal controls.  GeneSpring is a highly specialized 
bioinformatics software program that is able to associate the Affymetrix probes 
with genes as well as perform a quality control analysis.  The output of the 
GeneSpring analysis included box and whisker plots (Figure 4.1) and profile plots 
(Figure 4.2).  An applied table / excel file was created to provide gene and probe 
identifiers and used to generate the probe count histograms for significant Entrez 
genes at the SScore cutoff of 3 (Figure 4.3).  Upon confirming quality data 
(Figures 4.1 and 4.2), the significantly changed Entrez gene IDs numbers shown 
in Figure 4.3 were further analyzed to determine the fold change.  The fold 
change value for each significant gene compares the values at the experimental 
acidic pH condition (pHe 6.8) to those at the control neutral pH condition (pHe 
7.4).  
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Figure 4.1.2 
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Figure 4.1. GeneSpring quality control for intensity of fluorescent signals.  
Graphs, for the indicated number of probes, indicate the minimum (bottom of the 
lower whisker), the first quartile (lower border of the box), the median (line 
through the box), the third quartile (upper border of the box), and the maximum 
(top of the upper whisker) of the distribution of normalized fluorescent signals.  
Most signals are within 2 standard deviations (outliers are red bars) and are 
comparable within a single cell line at either of the two pHe’s: 7.4 or 6.8.   
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Figure 4.2.1 
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Figure 4.2.2 
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Figure 4.2.  Profile plots for intensity of fluorescent signals indicative of 
changes in transcripts. Normalized fluorescent signals of probes for each cell 
line grown in 3D rBM overlay cultures at either pH 7.4 (left) or 6.8 (right) are 
illustrated. Decreased signals are shown in red, unchanged in yellow, and 
increased in blue at the acidic pHe, using a paired expression analysis.   
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Figure 4.3.  Quality control histograms illustrating the number (1-6) of 
significantly changed probes at pH 6.8 to a single RefSeq gene ID.  
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4.2.4.3  Commonalities among the three DCIS cell lines 
The goal of our studies is to identify molecular mechanisms for acid-
mediated invasion using an unbiased method with a focus on the response of 
pre-invasive DCIS cells to acidic pHe.  We explored the commonalities among 
the three human DCIS cell lines upon exposure to acidic pH.  We chose to use 
the web-based program BioVenn to compare and visualize the overlap in 
significant gene expression lists because BioVenn allows visualization of area-
proportional Venn diagrams (Hulsen et al., 2008).  The Entrez gene IDs for the 
genes significantly changed at the acidic pHe for each of the three DCIS cell 
lines were entered into BioVenn.  The output Venn diagram has three circles with 
each circle corresponding to the total number of significantly changed genes for a 
single DCIS cell line (Figure 4.4).  The overlapping area between two circles 
represents the genes commonly changed in the two cell lines, whereas the 
central node of the Venn diagram represents genes commonly changed in all 
three cell lines.  The size of the circles and overlapping areas are proportional; 
for example, the largest circle corresponds to the largest number of significantly 
changed genes.  The numbers indicate significantly changed genes. There are 
only 7 common genes among all three DCIS cell lines (Figure 4.4).  The 7 Entrez 
IDs correspond with te following genes: ARG2 (Arginase, type II), ATP11B 
(ATPase, class VI, type 11B), IFI35 (interferon-induced protein 35), MTHFD1L 
(methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like), PBX2 
(pre-B-cell leukemia homeobox 2), S100P (S100 calcium binding protein P) and 
STAT1 (signal transducer and activator of transcription 1).   
	  	  
102	  
 
 
Figure 4.4.  Genes significantly changed at pHe 6.8 in three human DCIS 
cell lines.  BioVenn image depicts the proportional input of significantly changed 
genes.  The 102 genes in regions of overlap among two or more DCIS cell lines 
were used for subsequent IPA studies.  The  seven genes changed in common 
are ARG2, ATP11B, IFI35, MTHFDIL PBX2, S100P, and STAT1.   
 
 
 
Figure 4.4.   
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4.2.4.4 IPA core analysis 
To perform a proper pathway analysis the commonalities in two of three 
cell lines were analyzed for the 102 genes determined to be the DCIS response 
to acidic pH (Figure 4.4).  The 102 Entrez IDs identified in BioVenn were put into 
IPA and annotated to generate gene information.  Subsequently, these lists were 
run through an R-program “Make_FC_file.R” (provided as a supplemental file) to 
put together the Entrez ID and gene information with the fold change values for 
each gene of interest for each of the individual three DCIS cell lines.  In addition I 
compiled an average fold change value for the significantly changed 102 genes 
in the DCIS cells at acidic pHe.  This information is compiled in an excel file 
“propeller for IPASig3” (provided as a supplemental file). I used the average fold 
change values for the 102 significantly changed genes at the acidic pHe for two 
or more DCIS cell lines in IPA core analysis.  The average change values 
accurately represent the significant changes in each of the individual DCIS cell 
lines (i.e., the genes changed in a common direction and were close to the 
average values).  
The IPA core analysis is a powerful software that uses algorithms for data-
mining of published research with expert hand-curation by professionals to 
integrate molecular and chemical interactions.  IPA analysis of our data on 
response to acidic pHe revealed that the most significant pathway was interferon 
signaling in which the transcription factor STAT1 and several of its downstream 
targets were upregulated (Figures 4.5 and 4.6 and Table 4.6).  Collectively, our 
results suggest an important role for STAT1 signaling in response to acidic pHe 
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in three human DCIS cell lines of different origins.  This has led us to hypothesize 
that the interferon signaling pathway is upregulated under acidic growth 
conditions and may be important for survival and selection of cancer cells that 
are invasive in the acidic microenvironment surrounding solid tumors.  This 
pathway was absent in normal cells exposed to acidic pHe, such as N1ME 
myoepithelial cells and MFC-10A analyzed by the same methods (SScore 3 and 
FC determination) (Figure 4.7).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  	  
105	  
 
Figure 4.5.  Top canonical pathways, as determined by IPA core analysis, 
using the 102 genes identified in Figure 4.4.  The most significant pathway is 
interferon signaling in which 8 out of 36 genes in the pathway were significantly 
altered at the acidic pHe. 
Figure 4.5.   
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Figure 4.6. Interferon signaling pathway illustrating that in response to an 
acidic microenvironment STAT1 drives the transcriptional regulation of 
downstream target genes.  In this diagram, the canonical interferon signaling 
pathway is overlaid with the average significant fold-change value of the 102 
genes identified. All significantly changed genes (8) in the pathway (36 total) 
exhibit elevated transcription at pHe 6.8.  The darker the shade of red the greater 
the upregulation of expression: actual values are given in the insert to the left.   
Green would depict downregulation of expression at pHe 6.8; however, there 
were no genes in the pathway that are downregulated.  
 
 
Symbol FC 
 IFI35  1.854 
 IFIT1  2.106 
 IFITM1  1.890 
 IRF9  1.433 
 MX1  1.917 
 OAS1  1.605 
 PSMB8  1.334 
 STAT1  1.271 
Extracellular 
Nucleus 
Figure 4.6 
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Table 4.6. Seven upregulated downstream target genes of STAT1-driven 
interferon signaling.  Gene symbols, names and average fold change values 
are identified. 
  
 
Seven Upregulated Downstream Targets 
Average fold 
change 
IFITM1 interferon induced transmembrane protein 1 2.313 
PSMB8 proteasome subunit, beta type, 8 1.423 
IFI35 interferon-induced protein 35 1.854 
IRF9  interferon regulatory factor 9 1.459 
IFIT1 interferon-induced protein with 
tetratricopeptide repeats 1 
2.513 
OAS1  2',5'-oligoadenylate synthetase 1 1.705 
MX1 myxovirus resistance 1 2.254 
Table 4.6.  
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Figure 4.7.  Interferon signaling pathway illustrating that in non-
transformed cells STAT1 does not drive the transcriptional regulation of 
downstream target genes in response to an acidic microenvironment.  In 
this diagram, the canonical interferon signaling pathway overlaid with color to 
indicate the significant fold change values of the diploid MCF10A (A) and 
myoepithelial N1ME (B) cells identified at an SScore of three (see Table 4.5).  
The darker the shade of red the greater the upregulation of expression; green 
depicts downregulation of expression at pHe 6.8.  Although STAT1 is 
upregulated in MCF-10A acini, there is little indication of activation as indicated 
by the absence of changes in downstream target genes.   
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STAT1, or Signal Transducer and Activator of Transcription 1, is a well-
studied transcription factor that mediates stress responses that regulate cell 
growth, differentiation, apoptosis and immune functions.  There is debate in the 
field as to whether its role in cancer is as a suppressor or a promoter.  
Traditionally, STAT1 is characterized as a tumor suppressor due to its role in 
restraining growth and increasing cellular apoptosis (Khodarev et al., 2010; 
Pitroda et al., 2009).  Consistent with STAT1 being a tumor suppressor is that it 
is down-regulated in human squamous cell head and neck cancer and plays a 
protective role against development of carcinogen-induced and spontaneous 
cancer, which is absent in STAT1 deficient mice (Efimova et al., 2009; 
Shankaran et al., 2001).  Recently, new functions are emerging for elevated 
STAT1: 1) resistance to cancer therapies such as ionizing radiation (Amundson 
et al., 2004) and chemotherapy (Khodarev et al., 2009; Thomas et al., 2004); 2) 
transcriptional regulation of proteins involved in glycolysis (Warning et al., 2011); 
and 3) up-regulation of IL-6 and IL-8 (Efimova et al., 2009).  IL-6 and IL-8 are 
both cytokines of interest in our laboratory as they are associated with increased 
invasiveness of breast cancer (Mohamed et al., 2010).  We have found that 
STAT1 is upregulated in response to acidic pHe, whereas others have observed 
STAT1 upregulation in response to hypoxia (Lee et al., 2006).  Hypoxia and pHe 
are common conditions in solid tumors and are very difficult to study 
independently in vivo.  STAT1 has been shown to have a role in altering 
glycolytic pathways (Pitroda et al., 2009), suggesting an important role for this 
transcription factor in the development of an acidic extracellular pH.  STAT1 
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mediates stress responses regulating cell growth, differentiation, apoptosis, and 
immune functions, but its role in cancer is still not clearly defined.  Our finding 
that STAT1 and downstream factors are upregulated in DCIS cells in response to 
acidic pHe indicates that STAT1 warrants further investigation as a tumor 
enhancer in pre-invasive carcinoma and may lend credence to targeting these 
pathways earlier in cancer progression for therapeutic benefit. 
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SUMMARY AND FUTURE DIRECTIONS 
The purpose of this dissertation work was to examine the effects of an 
acidic tumor microenvironment (acidic pHe) on proteolysis and gene expression 
in breast carcinoma.  Our study builds on strong previous reports that support the 
hypothesis that the acidic environment generated by tumors is integral to their 
ability to invade, i.e., the acid-mediated invasion hypothesis (Chapter 1.4).    For 
our studies we used 3D rBM overlay cultures and examined the effects on 
proteolysis and gene expression of the cells at acidic (6.8) compared to a neutral 
(7.4) pHe.  The pHe of 6.8 was chosen as our test condition because it is 
representative of the average pHe in human breast carcinomas.  We were able 
to show that maintaining invasive carcinoma cells in 3D rBM overlay cultures at 
an acidic pHe resulted in an increase in the degradation of the basement 
membrane protein, type IV collagen, and demonstrate that this increase was due 
in part to an elevation in the levels of active cysteine cathepsins adjacent to the 
outer surface of the tumor cells (Chapter 3). We also did a microarray study on 
breast cell lines cultured in 3D rBM overlay cultures at an acidic pHe.  The results 
of the bioinformatic analyses led to the hypothesis that STAT1-signaling has an 
important oncogenic role in DCIS cells exposed to an acidic pHe (Chapter 4).  
The new insights derived from these analyses lay the groundwork for future 
experiments.    
 The studies described in Chapter 3 used GB123, an ABP that is selective 
for a number of cysteine cathepsins, namely cathepsins B, L, and S.  We were 
able to identify and pull-out ABP-bound cathepsin B and cathepsin L from MDA-
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MB-231 cell lysates.  By culturing MDA-MB-231 and two other invasive 
carcinoma cells in 3D rBM overlay cultures at acidic pHe, we demonstrated both 
a dramatic increase in general proteolysis that could be reduced by a highly 
selective cathepsin B inhibitor (i.e., CA074) and an increase in the pericellular 
localization of the active enzyme using GB123.  The increased proteolysis at the 
acidic pHe and proteolysis at the neutral pHe was only partially reduced by 
inhibition of cathepsin B.  Therefore our study should be expanded because 
additional proteases must participate in the proteolysis.  There are currently 
ABPs available for other cysteine proteases such as legumain (Edgington et al., 
2013) as well as other proteolytic families such as serine proteases (Liu et al., 
1999) and MMPs (Keow et al., 2012).  By using inhibitors that are selective for 
different proteases and synthetic substrates for a variety of proteases, one 
should be able to gain a comprehensive look at how the acidic pHe influences 
the activity of proteases leading invasion and metastasis.    Additionally, by 
moving to quenched ABPs that do not fluoresce before interacting with the 
enzyme we could reduce the time required for removal of unbound probes 
allowing analysis of more samples (Chapter 2.4).   
The studies could also be expanded to include multiple cell types in the 
MAME cultures because we have shown that different cell types present in the 
tumor microenvironment can modulate the breast cancer proteolysis.  For 
example, tumor associated fibroblasts in co-culture with breast or colon cancer 
cells increase degradation of DQ-collagen IV by 3-15 fold (Sameni et al., 2009; 
Sameni et al., 2003) and myoepithelial cells are able to reduce the degradation 
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(Sameni and Sloane, in preparation).  Another microenvironmental component 
closely related to pHe is oxygen availability and experimental protocols could be 
designed to look at the degradation and or presence of proteases under acidic 
and hypoxic conditions.   
 To confirm the findings described in Chapter 4 it will be necessary to 
validate the microarray results.  Validation studies have been started by looking 
for STAT1 and the downstream transcriptional targets through quantitative RT-
PCR of the three available cell lines of human DCIS cultured the same as they 
were for the microarray.  After validation at the transcript level, expression of 
proteins can be verified through western blotting and/or by quantitative proteomic 
techniques.   We, in collaboration with the Gillies laboratory, have assembled a 
list of proteins of interest including the STAT1 canonical pathway members that 
will be analyzed by liquid chromatography-multiple reaction monitoring-mass 
spectrometry (LC-MRM-MS). Those results should then be evaluated for 
commonalities and discordances with the microarray data using BioVenn and 
pathway analysis software such as IPA.  We expect that such additional analyses 
will confirm the original microarray data, which suggests that an acidic pHe 
induces up-regulation of the STAT1 signaling pathway in DCIS cells.   
We showed that carcinoma cell lines grown in 3D rBM overlay cultures 
survive and proliferate at an acidic pHe, thus exhibiting an acid-resistant 
phenotype (Figure 3.4).   We predict that in vivo DCIS lesions acquire an acid-
resistant phenotype during the intermittent hypoxic conditions found during 
cancer progression (Figure 1.4); however the characterization of acid-resistance 
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has yet to be performed in human DCIS cells in vitro.  We anticipate mixed 
results with respect to acid-resistance among the DCIS cell lines due to their 
different origins, which were described in Chapter 4.1.  Preliminary findings of 
acid-resistance, using an MTT assay, have confirmed that there are differences, 
but further studies using proliferation and live-dead assays should provide 
additional information.  The current study might have been confounded by 
toxicities due to the acidic pHe; however, visual observation (J. Dosescu) did not 
support toxic effects.  If the acid-resistance or lack-there-of is of concern, 
comparisons with DCIS cells that have been uniformly adapted to an acidic-pHe 
(a method that has been described previously (Wojtkowiak et al., 2012)) or 
comparisons with primary cultures of human DCIS could be undertaken. Since 
our study began costs of running microarrays have gone down, and it may be 
worthwhile to repeat the microarray to make these comparisons.  
Molecular responses that result in both increased proteolysis and STAT1 
signaling begin by sensing and relaying the detection of acidic pHe.  To our 
knowledge the expression of ASICs in breast epithelium and in breast cancer has 
yet to be characterized.  Macrophages express ASICs 1 and 3 and respond to an 
acidic pHe by increasing endocytosis (e.g., for antigen presentation) and exocytic 
secretion of cytokines (Kong et al., 2013).  Previous reports by our laboratory and 
others have shown an important role for macrophages in the secretion of 
cysteine cathepsins in cancer (Gocheva et al., 2010; Mohamed et al., 2010; 
Vasiljeva et al., 2006).  Others have reported expression of ASICs in gliomas that 
parallel their invasiveness (Berdiev et al., 2003). On the other hand, increases in 
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expression and activity of cathepsin B in gliomas correspond to increased 
invasiveness (Rempel et al., 1994).  A direct link between ASICs and regulation 
of cysteine cathepsin secretion needs to be examined.  There may also be 
interactions between STAT1 signaling and ASICs as both activate PI3K signaling 
(Brown and Wagner, 2012; Chu et al., 2011; Duan et al., 2012; Fruhbeck, 2006).  
STAT1 supports oncogenic growth and up-regulates genes driving 
glycolysis/gluconeogenesis suggesting a role in mediating the high glycolytic 
phenotype of tumors (i.e., Warburg effect) (Pitroda et al., 2009) and thus the 
development of the acidic pHe observed in solid tumors. Therefore, both STAT1 
and ASIC signaling pathways warrant further investigation independently as well 
as in regard to possible cross-talk between the two pathways in the progression 
from DCIS to invasive carcinoma.   
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ABSTRACT 
ACIDIC PERICELLULAR PH: EFFECTS ON PROTEOLYSIS AND GENE 
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Among the non-cellular microenvironmental factors that contribute to 
malignancy of solid tumors is an acidic peritumoral pH. The first objective was to 
determine if an acidic extracellular pH observed in vivo (i.e., pHe 6.8) affects the 
activity of proteases, such as cathepsin B, that contribute to degradation of 
collagen IV by tumor cells when grown in biologically relevant three-dimensional 
cultures.  At pHe 6.8 there were increases in pericellular active cysteine 
cathepsins and in degradation of DQ-collagen IV, which was partially blocked by 
a cathepsin B inhibitor.  Imaging probes for active cysteine cathepsins localized 
to tumors in vivo. The amount of bound probe decreased in tumors in 
bicarbonate-treated mice, a treatment previously shown to increase peritumoral 
pHe and reduce local invasion of the tumors. Our results are consistent with the 
acid-mediated invasion hypothesis and with a role for cathepsin B in promoting 
degradation of a basement membrane protein substrate, i.e. type IV collagen, in 
an acidic peritumoral environment.  The second objective was to use a 
microarray approach to identify significantly altered genes that may be of 
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importance in the response to acidic pH in ductal carcinoma in situ (DCIS). We 
have found that STAT1-directed signaling is up-regulated in response to acidic 
pH extracellularly. Its role in altering glycolytic pathways suggests an important 
role for this transcription factor in the development of an acidic extracellular pH. 
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